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Process Analytical Technology (PAT) is framed with the objective of the 
design and development of processes to ensure predefined quality of the 
product at the end of manufacturing. PAT implementation includes better 
understanding of process, reduction in production time with use of in-line, at-
line and on-line measurements, yield improvement and energy and cost 
reductions. 
Hot Melt Extrusion process (HME) used in the present work is proving 
increasingly popular in industry for its continuous and green processing 
which is beneficial over traditional batch processing. The present work was 
focused on applications of Raman spectroscopy as off - line and in - line 
monitoring techniques as a PAT for production of pharmaceutical solid 
dispersions and co-crystals.  
Solid dispersions (SDs) of the anti-convulsant Carbamazepine (CBZ) with 
two pharmaceutical grade polymers have been produced using HME at a 
ii 
 
range of drug loadings and their amorphous nature confirmed using a variety 
of analytical techniques. Off-line and in-line Raman spectroscopy has been 
shown to be suitable techniques for proving preparation of these SDs. 
Through calibration curves generated from chemometric analysis in-line 
Raman spectroscopy was shown to be more accurate than off-line 
measurements proving the quantification ability of Raman spectroscopy as 
well as a PAT tool. 
Pure co-crystals of Ibuprofen-Nicotinamide and Carbamazepine-
Nicotinamide have been produced using solvent evaporation and microwave 
radiation techniques. Raman spectroscopy proved its superiority over off-line 
analytical techniques such as DSC, FTIR and XRD for co-crystal purity 
determination adding to its key advantage in its ability to be used as an in-
line, non-destructive technique. 
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Chapter 1 - Introduction 
1.1. General Introduction 
Since there is an increasing demand in the process optimization and product 
quality improvement within the pharmaceutical industries, less time 
consuming and novel analytical techniques are becoming a focus within 
related research.  
Quality by Design (QbD) is a scientific and proactive approach to 
pharmaceutical development based on the concept that quality should be 
‘built-in’ by proper design than being simply reliant on end product 
performance (ICH, 2009). Based on the QbD concept, Process Analytical 
Technology (PAT) applies innovative scientific and engineering principles for 
the assessment of pharmaceutical product design, analysis and process 
quality. It ensures a predefined quality of products after the production 
process which may improve production time, use of materials and energy 
utilized for production (Scott and Wilcock, 2006). 
A review of the history of identification of polymorphic forms indicates the 
wide scale use of off-line analytical techniques such as Fourier Transform 
Infrared spectroscopy (FTIR), Nuclear Magnetic Resonance spectroscopy 
(NMR), Differential Scanning Calorimetry (DSC) and Powder X-ray 
Diffraction (PXRD) (Braatz, 2002 ). However, these analytical techniques do 
not provide continuous process information and may alter processing history. 
Near infrared (NIR) spectroscopy (Fevotte et al., 2004; Kobayashi et al., 
2006) and Raman spectroscopy (Agarwal and Berglund, 2003; O’Brien et al., 
2004; Wang et al., 2000) have been utilized for the characterization of crystal 
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form and conversion kinetics as PAT tools. Ability of the same methods for in 
- line studies along with their off - line characterization capacity is a novel 
application.  
This report is concerned with the application of in - line Raman spectroscopy 
as a PAT technique for the assessment of solid dispersions during the hot 
melt extrusion (HME) process as well as the development of Raman as a 
technique for monitoring production of co-crystals using extrusion. The 
present work in this report focuses on applications of solid dispersions, co - 
crystals, HME and Raman spectroscopy along with discussion on the 
significance and challenges associated with the techniques. 
1.2. Process Analytical Technology (PAT) 
The design and development of processes to ensure predefined quality of 
the product at the end of manufacturing is the desired goal of PAT. The need 
and the challenge of the US FDA’s (United States Food and Drug 
Administration) PAT initiative are of great concern for the manufacture of 
pharmaceutical formulations. PAT was introduced in 2004 by the US FDA for 
building inherent quality within pharmaceutical products (USFDA, 2005). PAT 
is a joint initiative of the Centre for Drug Evaluation and Research (CDER), 
Office of Regulatory Affairs (ORA) and the Centre for Veterinary Medicine 
(CVM) within the ‘Current Good Manufacturing Practices (cGMPs) for the 
21st Century’ framework (FDA, 2004b).  
The objective of PAT implementation includes better understanding of 
process, reduction in the production time with use of in-line, at-line and on-
line measurements, yield improvement and cost reduction because of less 
energy consumption. The PAT framework consists of various tools for 
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pharmaceutical developments such as multivariate data acquisition and 
analysis tools, process analysers, process monitoring and continuous 
knowledge improvement tools. In multivariate analysis, the foundation for the 
product and process design is considered. Mathematical models can be 
used to assess reliability of this knowledge (Eriksson et al., 2001; FDA, 
2004a). 
The understanding of the interaction between process and product is the 
basis for the design of the process monitoring, process control and Quality 
Assurance (QA) strategies used in manufacturing. PAT is an integrated 
approach in which the results obtained from the real-time analysis of critical 
process control points are used to control the process in some way. During 
manufacturing, process parameters are adjusted (within clearly defined 
limits) to produce the desired product quality attributes at the process end-
point. The automation systems required for this level of process control are 
available today and are used extensively in the chemical and petrochemical 
industries. 
Methods used with PAT include Near-Infrared (NIR) spectroscopy, Raman 
spectroscopy, UV - visible spectrophotometry, Fourier Transform Infrared 
(FTIR) spectroscopy, X-Ray Powder Diffraction (XRPD), Terahertz Pulse 
(TP) spectroscopy, NIR microscopy, Acoustic Resonance (AR) spectrometry 
etc. The validation plan for a PAT system includes the validation of the 
process analyser hardware and software, software packages for data 
analysis, process control software, and IT systems for the management, 
storage and backup of results (FDA, 2002). These modern process analytical 
tools provide non -destructive methods for processing of materials and can 
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contain information related to the biological, physical, and chemical aspects 
of the materials being processed.  
On-line monitoring 
On-line monitoring involves the automated sampling by transport of the drug-
polymer melt away from the main process, using a heated sample line, to a 
nearby analyzer for continuous analysis (Chalmers, 2000). This type of 
monitoring can be time consuming, and often results in perturbation of the 
process by removal of the melt stream. On - line methods of analysis 
therefore often involve samples which are not representative of the melt flow. 
Since on-line measurements are conducted away from the main process in a 
controlled measurement environment more stable analysis of the melt can be 
carried out, without being affected by fluctuations of temperature and 
pressures in the main process.  
At - line monitoring 
Here the sample is removed and isolated from the process stream and 
analyzed in the close proximity to the process stream. 
In - line monitoring 
During in - line monitoring, probes can be used which focus directly into the 
process through a suitable window or can be directly inserted into a process 
line. Such methods are often non-invasive allowing real - time, continuous 
process analysis of the melt without disturbing the process line. In - line 
monitoring for material characterisation during processing is continuously 
increasing both in use and scope with analytical techniques rapidly 
developing from conventional off - line laboratory based methods, to real - 
time analysis during processing (FDA, 2004a). Examples of process 
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analysers include process rheometers which can be used directly in or at the 
process flow and can be useful in material characterisation for determination 
of viscosity, composition and uniform mixing capacity. 
1.3. Raman spectroscopy 
1.3.1. Background 
A series of experiments was performed by C.V. Raman and K.S. Krishnan 
which involved focusing sunlight onto samples of purified liquids or gases 
(Raman and Krishnan, 1928). The Raman effect was actually predicted 
some five years earlier by Smekal, and the same effect was also observed 
by Landsberg and Mandelstam at about the same time as Raman’s 
discovery, but because Raman’s paper represented the more thorough 
study, Raman was awarded the Nobel Prize in 1930 (Simonson, 2004). 
Raman spectroscopy is gaining more popularity in the area of 
pharmaceutical research. Since among all the spectroscopic techniques, 
Raman spectroscopy possesses a unique identity due to its specificity, high 
information content and ease of sampling (Kepa et al., 2012). 
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Fig.1.1. Raman spectroscopy (Adapted from Exeter, 2013). 
1.3.2. Principle 
The schematic presentation of Raman spectroscopy is given in Fig. 1.1. The 
Raman scattering technique is a vibrational molecular spectroscopy which 
derives from an inelastic light scattering process. It involves focusing a laser 
onto the sample and recording the energy profile of the scattered light. 
Unique spectra may be obtained due to excitation of the vibrational modes of 
the molecule and, for mixed samples, superimposition of the signals from 
each of the constituents may be observed (Kalantri et al., 2010). The energy 
of laser light produced by lasers used in Raman spectroscopy is higher than 
the energy required to bring molecules to a higher vibrational state.  
During Raman study, at the same frequency (as that of energy), sample 
molecules scatter most of the energy. This identically scattered light is known 
as Rayleigh radiation. Light scattered by the molecules inelastically indicates 
the energy exchange between the incident light and the sample. This 
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inelastic scattering is termed as the Raman effect. The inelastic scattered 
radiation with probably lower energy than the incident radiation is known as 
Stokes radiation while the incident radiation with higher energy is called anti-
Stokes radiation (Saerens et al., 2011). A typical modern Raman 
spectrophotometer is shown in Fig. 1.2. 
 
 
Fig.1.2. DXR smart Raman spectrophotometer (780nm) by Thermo 
Scientific (Thermofisher.com) 
1.3.3. Advantages of Raman spectroscopy  
These include minimal or no sample preparation, fast collection of spectra, 
and high sensitivity to molecular geometry. Raman spectroscopy is a non-
destructive method of analysis when correctly applied, so the same sample 
can be used in other analyses and is also a non-invasive method which can 
even work within sealed transparent containers (Fini, 2004). Small volumes 
of materials can be analysed, as the laser can be focused to a very small 
spot.  
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1.3.4. Challenges associated with Raman spectroscopy 
Colored samples may undergo thermal or photochemical decomposition. 
Based on the sensitivity of the technique it can be concluded that it is most 
suited for studies of concentrated species (Bolton and Prasad, 1978). The 
same authors indicate that for low species concentration, it may be difficult to 
obtain quantitative information from Raman data. The cost of the equipment 
can be a limitation to the widespread adoption of Raman spectroscopy for 
routine analysis and high levels of fluorescence (intrinsic or caused by 
impurities) may also overlay the Raman bands making analysis difficult. This 
may sometimes be avoided by shifting the laser wavelength to the NIR 
spectral region however, if excitation intensities are too high, they may 
thermally decompose the sample (Saerens et al., 2011). 
1.4. Extrusion 
The word extrude means to push out in the process of extrusion wherein a 
material is forced by an extruder through an orifice die under set conditions 
such as temperature, pressure, rate of mixing and feed rate for producing a 
stable product of uniform shape and density (Saerens et al., 2011). Extrusion 
may be sub-classified into ram extrusion (Fig. 1.3), single screw extrusion 
and twin screw extrusion (Fig. 1.4). 
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Fig.1.3. Ram extrusion (Rauwendaal, 2001) 
 
 
Fig.1.4. Cross section of single and twin screw extrusion (Particle 
sciences, 2011). 
 
Single screw extrusion is not the preferred approach for the production of 
pharmaceutical formulations since it does not provide the high mixing 
capability of a twin screw machine. To achieve satisfactory dispersion and 
mixing of drugs with other ingredients may involve the breaking up of 
aggregates of the minor drug particles, meaning that a critical amount of 
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force must be applied during the process (Douglas et al., 2010). This force 
cannot be achieved with the single-screw, but the twin-screw extruder with its 
co-rotating or counter-rotating screws can provide the high energy necessary 
(Fig. 1.5). In addition, the versatility of a twin-screw extruder (process 
manipulation and optimisation) and the ability to accommodate various 
pharmaceutical formulations makes it much more favourable and hence it is 
the preferred choice for pharmaceuticals. Comparison points between single 
screw and twin screw extruders are listed in table 1.1. Another significant 
design variable is whether the two screws are intermeshing or non-
intermeshing, the former being preferred due to the greater degree of 
conveying achievable and the shorter residence times. (I. and E., 2003). 
Screws and kneading elements are showed in Fig. 1.6.   
 
 
Fig.1.5. Co-rotating and counter-rotating screws (Particle sciences, 2011) 
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Fig. 1.6.Screw and kneading elements (Chokshi and Zia, 2004). 
 
Sr. 
No. 
Single screw extruder Twin screw extruder (TSE) 
 
1. Used in simple profile extrusion 
and co-extrusion 
Used in compounding profile 
and reactive extrusion 
2. Modular design of screw and barrel 
is rarely used, less flexibility 
Often used with modular design 
of screw and barrel, great 
flexibility 
3. Prediction of extruder performance 
less difficult than for TSE 
Prediction of extruder 
performance is often difficult 
4. Fair feeding, slippery additives tend 
to cause problems 
Good feeding, can handle 
pellets, powder, liquids 
5. Fair degassing Good degassing 
6. Fair melting, continuous solid 
melting mechanism 
Good melting, dispersed solids 
melting mechanism 
7. Poor mixing ability Good distributive mixing with 
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effective mixing elements 
8. Not self-wiping, barrel is wiped but 
screw root and flight flanks are not 
Intermeshing can have 
completely self-wiping 
characteristics 
9. Relatively inexpensive Modular is very expensive 
10. Usually run between 10-150 rpm; 
high screw speeds possible but not 
often used 
Co-rotating can run at very high 
screw speeds - up to 1400 rpm 
 
Table 1.1.  Comparison between twin screw and single screw extruder 
(Rauwendaal, 1986b). 
1.5. Hot melt extrusion 
Hot melt extrusion involves a platform supporting a drive system, an 
extrusion barrel, a rotating screw arrangement on a screw shaft and an 
extrusion die for the shape of the final product (Fig. 1.7.). The extrusion 
barrel is divided into different zones such as the feeding zone, the 
compression zone and the metering zone. In the feeding zone (where 
material enters the conveying screw arrangement) pressure is very low due 
to large screw flight depths and pitch allowing consistent feeding from the 
hopper (s) and gentle mixing of these materials. The basic function of the 
subsequent compression zone is to melt, homogenize and compress the 
extrudate so that it reaches the metering zone in a suitable form for 
extrusion. Finally the compounded / mixed material enters the die geometry 
allowing a controlled and continuous production process (Williams, 2010). 
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Fig.1.7. Hot melt extrusion process (Fevotte et al., 2004). 
HME has been used successfully in many industries (plastic, food and rubber 
etc.) and has found recent applicability within the production of 
pharmaceutical formulations (Wilkinson and J., 1998). It has been proven 
that hot melt extrusion technology may improve the dissolution rate of poorly 
water-soluble drugs by forming solid dispersions and solid solutions 
(McGinity et al., 2001; Perissutti et al., 2002). A modern pharmaceutical 
grade hot melt extruder by Thermo Scientific is shown in Fig. 1.8. 
 
Fig.1.8. Hot melt extruder (Thermo Scientific Pharma HME 16) 
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During in-line monitoring by Raman spectroscopy, one has to take into 
consideration processing as well as formulation parameters such as drug 
and polymer melt ratios, temperature, motor load, die and extruder 
geometries. 
Advantages of HME over traditional pharmaceutical processing techniques 
can include: 
1. It is a solvent-free process. 
2. It has a short residence time. 
3. It may enable superior mixing. 
4.  It can form solid dispersions of enhanced bioavailability and dissolution 
rate of drugs with poor water solubility. 
5. It can produce products with controlled, sustained, modified and targeted 
drug release. 
6. It allows in-line monitoring along with control of critical process 
parameters. 
7. It can play an important role in masking the bitter taste of several APIs 
(Breitkreutz et al., 2003; Chokshi and Zia, 2004). 
Various parameters such as screw configurations, temperature profiles, 
material feed rates, screw geometry and screw speed can influence the 
products extruded by the HME process.  
1.6. Solid dispersions 
The term solid dispersion is used to describe the dispersion of one or more 
active ingredients in an inert carrier or at solid state prepared by melting 
method (Chiou and Riegelmann, 1971; Lewis et al., 2009). The matrix 
material may be in either crystalline or amorphous form. The drug can be 
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dispersed molecularly, in amorphous particles or in crystalline particles. The 
formation of high surface area results in an increased dissolution rate and 
consequently, improves bioavailability. Solid dispersions may be classified as 
first generation, second generation and third generation solid dispersions. 
In first generation solid dispersions, crystalline carriers have been used. 
Examples of such carriers include urea (Goldberg, 1966; Sekiguchi and Obi, 
1961; Sekiguchi and Obi, 1964) and sugar (Goldberg, 1966). Levy and Kanig 
(Kanig, 1964) formulated solid dispersions containing mannitol as a carrier 
by preparation of solid solutions through molecular dispersions which 
showed faster dissolution of the carrier. Since first generation solid 
dispersions were not stable enough and might not be as effective as the 
amorphous formulations, second generation solid dispersions came into 
existence. The most common solid dispersions use amorphous carriers 
rather than crystalline. Due to the ability of polymeric carriers to formulate 
amorphous solid dispersions, they have been the most successful for solid 
dispersions. Polymorphic carriers are classified as natural product-based 
polymers and fully synthetic polymers. Natural polymers used include 
Hydroxypropylmethyl Cellulose (HPMC) (Ohara et al., 2005; Won et al., 
2005), Ethyl Cellulose or Hydroxypropyl Cellulose (Tanaka et al., 2005) as 
well as Cyclodextrins (Rodier et al., 2005) while examples of used fully 
synthetic polymers are Povidone PVP (van Drooge et al., 2006), 
Polyethylene Glycols (PEG) (Chiou and Riegelmann, 1970) and 
Polymethacrylates (Ceballos, 2005). The drug is found to be in 
supersaturated state in the second generation solid dispersions due to its 
forceful solubilisation in the carrier (Tanaka et al., 2005) (Urbanetz, 2006). It 
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has been proved that these types of solid dispersions provide better 
wettability and dispersibility of the drug by the carrier (Damian et al., 2000).  
1.6.1. Need for solid dispersions 
The solid dispersion technique can provide different processing and excipient 
options that allow for flexibility while formulating oral delivery systems for 
poor water-soluble drugs compared with other dosage forms. The 
Biopharmaceutical Classification System (BCS) has categorised drugs 
exhibiting low aqueous solubility and high membrane permeability as class II 
drugs (Amidon et al., 1995). Solid dispersion technologies are especially 
promising for improving the oral absorption and bioavailability of these BCS 
class II drugs.  
1.6.2. Applications of solid dispersions  
Solid dispersions have various applications such as increasing the solubility 
of poorly soluble drugs thereby increasing the dissolution rate, absorption 
and bioavailability, stabilising unstable drugs against hydrolysis, oxidation, 
isomerisation, photo-oxidation and other decomposition procedures, 
reducing the side effects of certain drugs, masking of unpleasant taste and 
smell of drugs, improvement of drug release from ointment creams and gels, 
avoiding undesirable incompatibilities and obtaining a homogeneous 
distribution of a small amount of drug in solid state (Arunachalam et al., 
2010; Lewis et al., 2009). The efficiency of taste masking by solid 
dispersions prepared by using hot melt extrusion has been evaluated. HME 
has been introduced for taste masking purposes of bitter APIs by use of taste 
masking polymers that create solid dispersions to prevent bitter drugs from 
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contacting taste buds of patient (Breitkreutz et al., 2003; Gryczke et al., 
2011; Michalk et al., 2008; Witzleb et al., 2011). 
1.6.3. Preparation of solid dispersions 
Among the various methods used for solid dispersion preparations, melting 
and solid evaporation are the two prominent processes (Vasconcelos et al., 
2007). 
A. Melting (or Fusion) method 
The term melting is preferred over fusion for the preparation of solid 
dispersions when the starting materials are crystalline in nature (Lewis et al., 
2009). The first pharmaceutical solid dispersions containing sulfathiazole and 
urea were prepared by Sekiguchi and co-workers (Sekiguchi and Obi, 1961). 
This preparation consists of melting of sulfathiazole in the urea followed by 
its cooling and pulverization of the final product. For cooling and solidification 
of final products, various processes have been used such as ice bath 
agitation (Pokharkar et al., 2006; Sekiguchi and Obi, 1964) solidification on 
petri dishes at ambient temperature inside a desiccator (Li, 2006; Owusu-
Ababio et al., 1998) as well as by immersing in liquid nitrogen (Yao et al., 
2005). In spite of its frequent use, this melting or fusion method has some 
limitations (Lewis et al., 2009). These include degradation of several drugs 
by the use of high temperatures (Serajuddin, 1999), incompatibility of drug 
and matrix resulting in inhomogeneous solid dispersions. Such 
inhomogeneity can be avoided using surfactants (Damian et al., 2002). 
Several modifications such as hot stage extrusion (Van den Mooter et al., 
2006), Meltrex (Breitenbach and J., 2003) or melt agglomeration (Seo, 2003) 
have been introduced to avoid limitations of the fusion method. In the hot 
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stage extrusion method, reduction in processing temperature can be 
achieved through the use of carbon dioxide as a plasticizer (Verreck et al., 
2007). This can allow the use of hot melt extrusion to thermolabile drugs 
(Verreck et al., 2006). It was observed that itraconazole or inutec solid 
dispersions prepared by hot stage extrusion resulted in glassy itraconazole 
while the same were partially glassy when prepared by a spray drying 
method. A patented solid dispersion manufacturing process, Meltrex, is 
based on the melting method. Solid dispersions can be prepared by melt 
agglomeration in a rotary process.  In the case of solid dispersions prepared 
by HME, melt extrusion is found to offer the potential to shape the molten 
drug-polymer mixture into oral dosage forms, implants or ophthalmic inserts 
(Breitenbach, 2002). Also compared to the traditional fusion method, HME 
offers continuous production making it suitable for large scale production. 
B. Solvent evaporation 
This method of solid dispersion preparation involve the dissolution of the 
drug and polymer in a common solvent such as chloroform (Ahuja et al., 
2007), ethanol (Yoshihashi et al., 2006) or a mixture of ethanol and 
dichloromethane (Tanaka et al., 2005). For instance, in the preparation of 
indomethacin solid dispersion, the drug and ethyl cellulose were dissolved in 
ethanol (Yoshihashi et al., 2006) and HPMC was suspended (Ohara et al., 
2005). The thermal degradation of drugs or carriers can be avoided by using 
organic solvent evaporation since it can occur at low temperatures (Won et 
al., 2005). Preparation of solid dispersions by solvent evaporation can be 
achieved by several ways such as vacuum drying (Wang et al., 2005), slow 
evaporation of the solvent at low temperature, heating the mixture using a 
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hot plate (Desai, 2006) or by freeze-drying. Solid dispersion of diazepam and 
povidone was prepared by a spray drying method using liquid nitrogen 
followed by the lyophilization of the suspension obtained (van Drooge et al., 
2006). 
1.6.4. Advantages of solid dispersions (SDs) 
 Particles with reduced particle size: molecular dispersions, such as 
SDs, represent the last state on particle size reduction, and after carrier 
dissolution the drug is molecularly dispersed in the dissolution medium. 
 Particles with improved wettability, strong contribution to the 
enhancement of drug solubility is related to the drug wettability improvement 
verified in SDs. 
 Particles with higher porosity - particles in SDs have been found to 
have a higher degree of porosity. 
 Poorly water soluble crystalline drugs, when in the amorphous state 
tend to have higher solubility.  
1.6.5. Challenges associated with solid dispersions 
A major limitation of SDs is recrystallisation since amorphous systems are 
thermodynamically unstable and tend to change to a more stable state 
during recrystallisation. In this case, molecular mobility can be used to 
govern the stability of SDs. The efficient mixing of the drug and polymer in 
one solution can be challenging when their polarities are different. It may 
affect solubility of drug and polymer in the same solution. For minimisation of 
drug particle size in the solid dispersion, the drug and polymer have to be 
dispersed in the solvent as finely as possible (Hernandez-Trejo et al., 2005). 
Another challenge with the solvent method is to prevent phase separation as 
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crystallisation of either the drug or the polymer during solvent removal. 
Drying at high temperatures can speed up this process and reduce the time 
available for phase separation while at high temperatures - the molecular 
mobility of drug and polymer remaining high favouring phase separation 
(crystallisation). Commercial applications of solid dispersions are limited 
despite a good deal of research in this area. Some products marketed 
include: Cesamet (Lily), Nabilone in PVP, Gris-PEG (Novartis), Griseofulvin 
in PEG, Sporanox (Janseen Pharmaceutical / J&J), Itraconazole in HPMC 
and PEG 20000 sprayed on sugar spheres. Limitations influencing the 
successful commercialisation of SDs include the expensive and laborious 
manufacturing methods, characterisation reproducibility and difficulty in 
formulation dosage form incorporation, drug stability and scale-up of the 
manufacturing process. 
1.7.  Co-crystals (Co-Cs) 
Introduction 
A co-crystal can be termed as a crystalline structure formed by two different 
or molecular entities where intermolecular interactions are such as hydrogen 
bonding take place instead of ionic interactions (Djuris et al., 2013).  Co-
crystallisation is considered as an alternative approach in the formulation 
development for solubility improvement in pharmaceutical field. 
Pharmaceutical co-crystals can be applied in the field of pharmaceutical 
development in order to improve physical properties of the API such as 
solubility, stability and bioavailability without any change in their chemical 
composition (Sekhon, 2009). 
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A lot of research has been carried out on pharmaceutical co-crystals 
preparation, characterisation and their polymorphism. Pharmaceutical co-
crystals are single- crystalline solids which involve an API and a co-crystal 
former (This co-former can be a drug or an excipient).Various 
pharmaceutical co-crystals have been reported in the literature such as those 
with Acetaminophen (Paracetamol), Aspirin, Ibuprofen etc (Sekhon, 2009).  
 
Fig. 1.9. Pharmaceutical solid forms (Abbott) (www.slideshare.net). 
Methods of preparation of Co-Cs (Sekhon, 2009). 
1. Slow solvent evaporation  
2. Forced evaporation  
3. Melting method  
4. Mechano-chemical methods  
5. Slurry conversion 
6. Melt crystallisation 
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During the preparation of co-crystals, various conditions play an important 
role such as uptake of moisture, aqueous solubility of co-crystals, solubility 
and dissolution of co-crystal reactants etc. 
1.8. Aim and objectives of present work 
 To carry out in-line Raman spectroscopic studies of the preparation of 
solid dispersions during the hot melt extrusion process alongside 
complementary off-line analytical techniques such as X-ray diffraction 
(XRD) and Differential Scanning Calorimetry (DSC) was the main 
objective of the present work. 
 The present work focuses on the suitability of Raman spectroscopy as a 
process analytical technique (PAT) tool for monitoring the stability of solid 
dispersions with active pharmaceutical ingredients in the polymer melt 
with respect to processing variables. In the present work, Raman 
spectroscopy has been used to understand the degradation mechanism 
of API during hot melt extrusion process. 
 To perform a study of co-crystal properties through different methods of 
preparation of co-crystals and assess the suitability of Raman 
spectroscopy for in-line monitoring of the continuous production of co-
crystals was an important objective. 
1.9. Structure of thesis 
Raman spectroscopic studies being the main objective of the present 
research work, the focus was on its implementation as a PAT technique. 
Present work describes with the results ability of Raman spectroscopy in  
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quantification of API. Carbamazepine being an API with low solubility and 
polymorphic nature was selected to be used in solid dispersion preparation 
with different polymers. Carbamazepine along with Kollidon VA64 and 
Soluplus has been used in the preparation of solid dispersions while 
Ibuprofen - Nicotinamide and Carbamazepine - Nicotinamide systems have 
been selected to be used in the present study which are discussed in detail 
in respective chapters. 
This thesis is distributed into six chapters. Chapter one gives a general 
introduction of Process analytical techniques, Raman spectroscopy, hot melt 
extrusion, solid dispersions and co-crystals. Chapter two describes a 
literature review behind Raman spectroscopy in pharmaceuticals while 
chapter three describes the experimental techniques applied in the present 
work. Details about the DSC, TGA, XRD, FTIR, HSM and Raman 
spectroscopy including Process Raman probe used for In-line monitoring of 
solid dispersions have been discussed in this chapter. Details about 
materials and experimental methods are given in chapter four. Chapter five 
describes the results and discussion while conclusions are given in chapter 
six.  
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Chapter 2 - Literature Review 
Spectroscopy is of great importance in pharmaceutical research and 
analysis. Vibrational spectroscopic methods including FTIR and Raman 
spectroscopy are applicable for drug characterisation especially in the 
structural elucidation of compounds.  
2.1. Process Raman spectroscopy 
In pharmaceuticals, Raman spectroscopy has been applicable in Quality 
assurance (QA), Quality control (QC), research and potential processes. It 
can be used as reaction monitoring tool for gaining information on the 
progress of reactions. 
2.2. Raman spectroscopy applications 
Raman spectroscopy has been found to be applicable in various areas of 
pharmaceutical research such as characterisation of drug materials, drug- 
excipient incompatibilities and formulation analysis (Spragg, 1995; 
Tensmeyer and Heathman, 1989). 
For the study of polymers, Raman spectroscopy has been used for many 
years. It can provide information on molecular microstructure, polymer 
density, polymerisation, polymer orientation and crystallinity (Bower and 
Maddams, 1989). Initial applications of Raman spectroscopy for studying 
aqueous-phase emulsion polymerisation have been discussed (Al- 
Khanbashi et al., 1998). Raman analysis of many compounds of 
pharmaceutical interest has been reported (Cutmore and Skett, 1993). 
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The successful use of Raman spectroscopy has been reported along with a 
partial least squares method for on-line monitoring of polymerisation of 
emulsions (Bauer et al., 2000).   
Raman spectroscopy can be used for dye uptake determination or 
measurement of the mechanical properties of polymer fibres (Wijk et al., 
1999). Raman spectroscopy has been employed for measuring the 
residence time distributions of material in a twin screw extrusion process 
(Ward et al., 1996). Claybourn and co-workers applied Raman spectroscopy 
to measure spectra of acrylate containing copolymers by emulsion 
polymerisation (Claybourn et al., 1994).  
Many reports have been found in literature about off- line laboratory analysis 
of fibres and films by using Raman spectroscopy for polyethylene (PE) and 
polypropylene (PP) (Arruebarren de Baez et al., 1995; Rull et al., 1993). 
2.3. Raman spectroscopy for pharmaceutical industry 
The pharmaceutical industry along with chemical industry started using 
Raman analysers for obtaining laboratory to pilot plant data and 
manufacturing process setting. For mapping active excipient distribution 
dispersive Raman spectroscopy is being used. Dispersive Raman 
spectroscopy has also been applied for reaction-monitoring, process 
monitoring and pilot-plant batch analysis.  
The formulated products in pharmaceutical industries contain additives, 
binders, excipients, active material, dyes as well as identification marks. 
Often active materials are crystalline in nature and possess high Raman 
scattering tendency while the excipients have a low Raman scattering which 
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can lead to fluorescent spectra. FT- Raman spectroscopy by this means 
proved its applications in formulated product analysis. On the other hand 
dispersive Raman spectroscopy with visible excitation can be applicable for 
active ingredient monitoring during process (Frank, 1999). Quality control 
checks on incoming products at Colgate-Palmolive have been carried out 
using Raman spectroscopy (Frank, 1998). 
For in-situ study of headspace gases in pharmaceuticals with vials Raman 
spectroscopy has been employed at the Wellcome Foundation in the United 
Kingdom (Gilbert et al., 1994). The same authors have described that 
Raman analysis has shown better C-H stretching modes than that of Infrared 
spectroscopy in pharmaceutical materials. For drug mapping of 
pharmaceutical formulations such as tablets, Raman spectroscopy (RS) has 
been used (Frank, 1999). For characterization of illicit drugs, due to its non-
destructive nature and minimum sample requirements, Raman spectroscopy 
was found to be a preferred method (Hodges et al., 1989). The application of 
Raman and NIR spectroscopy for the in- process monitoring of drug 
synthesis process and crystallization was reported (Rasanen and Sandler, 
2007). Use of RS for the in-line monitoring of the blending process of a 
binary mixture of diltiazem pellets and paraffinic wax beads has been 
reported. It has been investigated that Raman spectrometer also has 
applications in assessing powder mixture homogeneity (Wikstrom et al., 
2005). 
Raman spectroscopy has been applied for the quantitative, non-invasive 
probing of the bulk content of pharmaceutical capsules on the production line 
of (Eliasson et al., 2008). Confocal Raman microscope with an automated 
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stage has been used for producing high- resolution, three – dimensional 
maps of the multi- phase material composition (Andrew et al., 1998). 
Hydration-dehydration of carbamazepine and theophylline in the presence of 
excipients has been analyzed with Raman spectroscopy (Salameh and 
Taylor, 2006). Monitoring of non-isothermal seeded crystallization with phase 
transition was done by second degree method using Raman analysis (Hu et 
al., 2005). Bucindolol has been analyzed by Raman spectroscopy using a 
multivariate calibration (Niemczyk and Delgadolopez, 1998). 
The Royal Pharmaceutical Society of Great Britain had hosted a new 
technologies forum meeting about the significance of Raman spectroscopy 
within the pharmaceutical industry. Due to its modern automation capability, 
spectral acquisition from small size samples its becoming an indispensable 
tool in pharmaceutical analysis. 
A comparative study of NIR dispersive and FT - Raman analyzers for on- line 
monitoring of phosphorous trichloride have been carried out (Gervaso and 
Pelletier, 1997). RS has been used for the identification of polymorphic forms 
and crystallinity of various pharmaceuticals. The purpose behind the studies 
of polymorphism is understanding the various polymorphic forms of 
compounds and their thermodynamic stability which is significant in drug 
development process of pharmaceuticals. It has been observed that there 
can be differences between the Raman spectra between the amorphous and 
the crystalline forms of a compound (Langkilde, 1995; Langkilde et al., 1997). 
The stabilisation of amorphous indomethacin dimers in molecular dispersions 
with poly (vinyl pyrrolidone) (PVP) has been probed using Raman 
spectroscopy (Taylor and Zograti, 1997). Taylor and Zografi have used the 
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FT-Raman spectroscopic method to evaluate crystallinity of molecular 
substances in the homogeneous state (Taylor and Zograti, 1998). For testing 
levels of crystallinity of substances Raman spectroscopy has been 
suggested (Langkilde et al., 1997). In-situ Raman measurements of calcium 
carbonate polymorphic composition has been carried out in the presence of 
polymeric additives during the crystallisation process. Deeley et al. studied 
the difference between FTIR and Raman methods for detection of cortisone 
acetate polymorphism. Better results were obtained by Raman analysis 
(Deeley et al., 1991). Raman spectroscopy and FT-IR methods were found 
to be suitable for identification and quantitative determination of orthorhombic 
and monoclinic paracetamol in a powder mixture (Al-Zoubi et al., 2002). It 
has been shown that with high dosage paracetamol tablets and lufenuron 
tablets, identification of crystalline phases in drug products is possible with 
Raman spectroscopy (Szelagiewicz et al., 1999). Griesser and co-workers 
(Auer et al., 2003) investigated the use of near infrared FT-Raman 
spectroscopy for determination of polymorphic forms in various commercial 
drug products with polymorphic drug compounds. The same authors showed 
that thermodynamically stable polymorphic forms were found in drug 
products with meprobamate, sorbitol and carbamazepine (CBZ) while for 
solid dosage forms of acemetacin, phenylbutazone, famotidine and mannitol, 
metastable polymorphic forms were identified (Auer et al., 2003). Gorden, 
along with his co-workers, have carried out a thorough spectroscopic study 
of CBZ polymorphs. The Raman spectra of the two polymorphic forms of 
CBZ (forms III and I) were found to be different and it was found that a 
carboxamide group shows the prime structural difference between the two 
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forms. According to these authors the experimental spectra of CBZ revealed 
that IR is more polymorph sensitive than Raman spectroscopy (Strachan et 
al., 2004).  Polymorphism of crystalline drugs is becoming a serious issue by 
means of combinatorial chemistry in the process of new drug discovery. New 
chemical entities (NCE) possess a large number of functional groups which 
may result in crystallisation of these drugs in many polymorphic forms. The 
solubilities and dissolution rates of different polymorphic forms will be 
different along with their absorption and bioavailability. Raman has also been 
applied for the quantitative detection of the polymorphic forms of ranitidine 
hydrochloride in tablets (Strachan et al., 2004). The solid state 
transformation of CBZ from form III to form I was studied by O’Brien and 
colleagues by using FT Raman spectroscopy (FTRS). They have also 
reported that FTRS can be used for non-destructive in-situ and at-line 
analysis of polymorphic drugs (O’Brien et al., 2004). 
Tian et al. illustrated the use of RS to study the conversion of each 
polymorphic form of CBZ into its dihydrate. RS combined with partial least 
square analysis was used to generate quantitative models of binary and 
ternary mixtures of the different polymorphic forms of the dehydrate (Tian et 
al., 2006). Indomethacin has been used to illustrate the ability of FT-Raman 
to evaluate a low degree of crystallisation (Taylor and Zograti, 1997; Taylor 
and Zograti, 1998). Strachan et al. investigated the application of RS and 
Principal Component Analysis (PCA) of polymorphic mixtures of CBZ form III 
and I (Strachan et al., 2004). 
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2.4. Raman spectroscopy for in-line monitoring 
Raman spectroscopy also enables in-line measurements and has previously 
been used during hot melt extrusion to monitor polymer melts (Alig et al., 
2005; Barnes et al., 2005 ). To obtain in-process information related to the 
API, the polymorphic behaviour of the API and the homogeneity of content, 
PAT tools are of great importance.  In-situ turbidity measurements have been 
found to be applicable for determination of polymorphic form transformation 
along with off-line spectroscopic studies (Barnes et al., 2008). 
In-situ continuous qualitative analysis of the carbamazepine - nicotinamide 
co - crystallisation process has been carried out by Raman spectroscopy 
(Rodriguez-Hornedo, 2006). 
A Raman spectroscopic method has been developed for in-line and real-time 
monitoring of the homogeneity of the powder mixing processes by de Beer 
and researchers in Ghent using Diltiazem Hydrochloride as the API under 
study (de Beer et al., 2008). The correctness of the conclusions from Raman 
spectroscopy was assured by the use of simultaneous NIR spectroscopy 
which ultimately enhances the certainty of the use of process analysers. In 
various publications, polymorphism has been studied and approximately 
80% of marketed pharmaceuticals are found to exhibit polymorphism.  In the 
case of the anti-retroviral drug Ritonavir from Abbott Laboratories, due to the 
sudden formation of an unknown, thermodynamically more stable and much 
less soluble crystalline polymorph, many final products failed dissolution 
tests which led to a financial loss of approximately 250 million dollars. This 
case indicates that insufficient understanding of crystallisation mechanisms 
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of the polymorphs could cause serious problems (Chemburkar et al., 2000). 
In-line monitoring of the crystal phase composition during the crystallisation 
process has been carried out by Raman spectroscopy. The polymorphic as 
well as pseudo-polymorphic composition of the crystals as a function of time 
can be obtained from in-line Raman spectroscopy which gives important 
kinetic information on the phase transformation between solid forms 
(Starbuck et al., 2002). Savolainen et al. used in-situ Raman spectroscopy in 
combination with either partial least squares discriminant analysis (PLS-DA) 
or partial least squares (PLS) regression analysis to monitor and quantify the 
solid phase transitions that take place during dissolution of CBZ (Savolainen 
et al., 2009). Demonstration of the suitability of RS as a PAT tool for in-line 
quantitative monitoring of active coatings with validation of the applied 
Raman analytical method in agreement with ICH guideline Q2 (ICH, 2009) 
has been carried out. Application of NIR Raman spectroscopy in 
identification of pharmaceuticals inside amber USP (the United States 
Pharmacopoeia) vials using a library of spectra has been reported (Al-Zoubi 
et al., 2002). In the end point detection of the blending of a binary pellet 
mixture have been carried out by Raman spectroscopy (Vergote et al., 
2004). Using an immersion probe, in- line monitoring of low dose blend 
uniformity was determined by Raman spectroscopy. Romero-Torres et al. 
found applications of Raman spectroscopy for monitoring of pan coating in 
tablet manufacturing for determination of coat thickness (Romero et al., 
2005). Similar types of work have been reported by Muller et al for 
monitoring active coating process using Raman spectroscopy (Muller and 
Knop, 2010). Mannitol phase behaviour during freeze drying has also been 
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monitored during in-line lyophillisation by Raman spectroscopy (Romero, 
2007). 
In-line Raman monitoring of fluid bed granulation using a univariate method 
has been reported (Walker and Bell, 2009). For controlled crystallisation of 
final formation in-line monitoring of lyophilisation have been demonstrated 
with the aid of Raman spectroscopy (de Waard et al., 2010). Mantanus and 
co-workers demonstrated the suitability of Raman mapping for evaluation of 
the API homogeneity within the drug reservoir (Mantanus et al., 2011). RS 
has also been implemented in a twin screw extrusion process to determine 
the concentration of Irganox additives in polypropylene (Alig et al., 2005). For 
off-line confirmation of drug dispersion within PEO and interaction with PEO 
in extrudates, RS has been used (Li et al., 2006). It is reported that solid 
state properties of SDs prepared by HME and solvent co-precipitation 
process can be compared by use of RS (Dong et al., 2007). The higher 
solubility of amorphous solids is found to be due to their higher energy and 
molecular mobility compared to their crystalline counterpart (Norman et al., 
2011). Raman spectroscopy has been evaluated as a PAT tool to monitor 
the API concentration and polymer-drug melt solid state during 
pharmaceutical hot melt extrusion processes (Saerens et al., 2011). Recently 
Raman spectroscopy has been used to quantify polymorphic mixtures with 
methods ranging from simple univariate correlations to more complicated 
multivariate approaches (Croker et al., 2012). 
2.5. Pharmaceutical co-crystals   
It has been reported that co - crystallisation can be a better alternative for 
drug discovery processes in the pharmaceutical industry (Sekhon, 2009). 
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Various combinations of co - crystals have been reported in the literature. 
Synthesis of co-crystals of Piroxicam and carboxylic acids have been 
reported Co - crystals of Ibuprofen- Nicotinamide have been obtained by 
slurry conversion method by Soares and group (Soares and Carneiro, 2013). 
Polymorphism in Carbamazepine - Saccharin and Carbamazepine-
Nicotinamide co-crystals has been reported in the literature (Porter et al., 
2008). Polymorphs exhibit different stabilities and can convert from unstable 
forms to stable forms at certain temperatures range (Sreekanth et al., 2007). 
Polymorphism in co - crystals has been observed and reported. Co - crystals 
of Carbamazepine and Nicotinamide have been reported to exhibit in two 
polymorphic forms. Co - crystals of Carbamazepine and Saccharin have 
been reported to exhibit in two polymorphic forms (Porter et al., 2008). One 
more polymer - nucleated polymorph of Carbamazepine and Nicotinamide 
co-crystal has been reported (Rahman et al., 2011).  
Researchers from the University of Bradford have reported a solvent free 
continuous co - crystallisation (SFCC) method for preparation of Ibuprofen 
and nicotinamide co-crystals and its monitoring using NIR as a PAT tool 
(Kelly et al., 2012). Impact of components used in co - crystals on decreasing 
solubility of the molecular complex to be crystallised is useful for nucleation 
and growth of co - crystals of Carbamazepine - Nicotinamide (Rodriguez - 
Hornedo, 2006).  A method for Carbamazepine - Nicotinamide co-crystal 
generation pathways and kinetics using in-situ thermomicroscopy, 
spectroscopy and calorimetry studies has been reported (Rodriguez - 
Hornedo, 2006). Ali has reported solvent evaporation method for the 
preparation of Carbamazepine-Nicotinamide co-crystal using absolute 
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ethanol (Ali et al., 2014). A method (Fig. 2.1.) for synthesis of 
Carbamazepine - Nicotinamide co-crystals by a liquid - assisted grinding has 
been reported. 
 
 
Fig.2.1. Carboxamide group H- bond interaction (Patil, 2014). 
In-situ monitoring of Carbamazepine-Nicotinamide co-crystal intrinsic 
dissolution behaviour has been illustrated by Qiao (Qiao et al., 2013). It has 
been reported that formation of co-crystals occur due to hydrogen bonding 
between Carbamazepine and Nicotinamide since both provide hydrogen 
bonding donors and acceptors. In case of co-crystals of Carbamazepine - 4 -
amino benzoic acid (1:1 and 2:1), it has been observed that more the content 
of co-formers, more the stability of co-crystals. By co-grinding of 
Carbamazepine with Saccharin or with Nicotinamide co-crystals were 
obtained (Zaworotko, 2008). 
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Chapter 3 - Experimental Techniques 
 
Analysis of pharmaceuticals using various experimental techniques is of 
great importance especially in terms of confirmation of quality of 
formulations. Preliminary testing of starting materials, differences between 
properties of starting and end products give clear understanding of research 
methods. This chapter outlines the various experimental techniques used in 
this project including Thermo - Gravimetric Analysis (TGA), Differential 
Scanning Calorimetry (DSC), Powder X - ray Diffraction (PXRD), Rheology, 
Hot Stage Microscopy (HSM), High Performance Liquid Chromatography 
(HPLC), Fourier Transform Infra - red (FTIR) Spectroscopy and Raman 
Spectroscopy (RS). In Raman spectroscopy, DXR smart Raman 
spectrophotometer with universal platform for sampling (UPS) has been used 
for carrying out off - line Raman spectroscopic analysis whereas for in - line 
monitoring of solid dispersions during hot melt extrusion Process Raman 
probe by Inphotonics has been used. 
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 3.1. Thermal Analysis 
 A. Thermo-Gravimetric Analysis (TGA)  
TGA measures the amount and rate of change in the weight of a material as 
a function of temperature or time in a controlled atmosphere. TGA has been 
found useful in determination of the composition of multi-component 
systems, the thermal and oxidative stability of materials, the estimated 
lifetime of a product, decomposition kinetics of materials, the effect of 
reactive or corrosive atmospheres on materials, and also the moisture and 
volatile content of various materials (PerkinElmer, 2012). The Thermo - 
Gravimetric Analyser used in this project is shown in Figure 3.1. 
 
 
Fig. 3.1. Thermo - Gravimetric Analyser (TGA Q5000 by TA Instruments) 
(Eliasson et al., 2008). 
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The technique can characterise materials that exhibit weight loss or gain due 
to decomposition, oxidation, or dehydration. The typical TGA curve is shown 
in Fig. 3.2.   
 
 
 
Fig. 3.2. Typical TGA curve (TA Instruments, 2012). 
The instrument consists of several important parts such as the microbalance, 
furnace and thermocouples. During heating, an inert purge gas such as 
nitrogen or argon is used to prevent air-mediated oxidation or combustion. 
There are two separated sets of thermocouples, one is for measurement of 
sample temperature and usually located very close to the sample, while the 
other thermocouple measures the furnace temperature to facilitate steady 
and linear heating rate (Wilson and Haines, 2002). 
In this project TGA has been used to quantify degradation of CBZ and 
Kollidon VA64 in CBZ - Kollidon VA64 SDs. Also to determine moisture 
content in SDs of CBZ and Kollidon VA64 TGA has been found useful. TGA 
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study of CBZ and NA also carried out along with their co - crystals for the 
confirmation of purity. 
B. Differential Scanning Calorimetry (DSC) 
DSC is utilised to quantify changes in a material’s thermal properties (shifts 
in the melting point Tm and glass transition temperature Tg  etc. as shown in 
Fig 3.6.) and can provide information on the ‘form’ of a substance during 
thermal processing. The Differential Scanning Calorimeters - Q2000 and 
Discovery DSC by TA Instruments used in this project are shown in Figure 
3.3. 
 
 
Fig. 3.3. Differential Scanning Calorimeters – a) Q2000 and b) Discovery 
DSC by TA Instruments 
The temperatures of transformations, thermodynamics and kinetics of a 
process may be determined using DSC (Rutter, 2012). This technique is well 
established in the field of pharmaceuticals for thermal characterisation and 
has been found important in the assessment of amorphous and crystalline 
materials as well as in the characterisation of polymorphs and polymorphic 
transformations. 
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During DSC, transitions or energetic events are determined as a function of 
time and temperature against a standard reference. This happens as a result 
of heating and cooling of material or holding it isothermally for a length of 
time (Ford and Mann, 2012) (Cox, 1990). Instrument baseline heat flow has 
a significant impact on almost all differential scanning calorimetry (Ford and 
Mann, 2012). If instrument baseline is not correct, weak transitions such as 
glass transitions cannot be detected (Danley and Caulfield, 2015). 
Glass transition (Tg) in polymers  
The temperature at which a change in amorphous form of a material from a 
glossy to rubbery state occurs is known as glass transition temperature (Tg). 
Tg in semi- crystalline polymers can be observed by small fractions and 
hence glass transition of polymers is poorly visible in case of crystalline 
polymers which are 5% or less amorphous.  
 
Fig.3.4. DSC measuring cell (Netzsch, 2015). 
Measuring cell of DSC contains a furnace and an integrated sensor where 
positions are designated for sample and reference pans (Fig 3.4.). 
40 
 
The sensor area which plays an important role is attached to thermocouples 
or can be a part of thermocouple and due to this temperature difference 
between the sample and reference (DSC signal) allowing the absolute 
temperature of the sample or reference side to be recorded (Netzsch, 2015). 
Fig.3.5. shows transition enthalpy in DSC. 
 
 
Fig 3.5. Graph showing transition enthalpy (DSC) (Netzsch, 2015).  
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 Fig. 3.6. Typical DSC curve (adapted from www.dscsolution.net).  
 
Solids, liquids, powders, films and fibers of essentially any shape are 
encapsulated in metal pans and placed into a temperature and atmosphere-
controlled environment where the measurement occurs. Sophisticated and 
easy to use software permits a quantitative analysis of transitions as a 
function of temperature and time. The temperature range for transitions in 
the different materials can often overlap and experience is required to create 
methods, which can assist with interpretation of results.  
DSC measures only the sum or average value of the heat flow rate from 
overlapping processes which makes quantitative analysis of the individual 
processes impossible. For any DSC, the only way to improve sensitivity for 
detecting low energy transitions is to increase sample size and heating rate. 
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This however decreases resolution which is the ability to resolve a transition 
that occurs close to another in temperature. DSC thus cannot optimize both 
sensitivity and resolution in a single experiment (Thomas, 2005). 
C. Modulated Differential Scanning Calorimetry (MDSC) In standard 
DSC, with a single heating rate, a single heat flow rate signal is produced, 
which is the sum of all heat flows occurring at any point in temperature or 
time. The operating principle of MDSC differs from standard DSC in that 
MDSC uses two simultaneous heating rates - a linear heating rate that 
provides information similar to standard DSC, and a sinusoidal or modulated 
heating rate that permits the simultaneous measurement of the sample’s 
heat capacity. MDSC is superior to DSC since it can separate kinetic events. 
It also has the ability to resolve complex transitions into specific components 
which can improve data interpretation. One further benefit of MDSC is its 
ability to measure heat capacity changes during reactions under isothermal 
conditions and also the measurement of the initial crystallinity of polymers 
and other materials (Thomas, 2005). 
In this project DSC has been utilised for confirmation of purity of APIs and 
polymers by means of their melting points, glass transition values and to find 
out differences in thermal changes in the starting materials (APIs, polymers 
along with their physical mixtures) and formulations after preparation. Purity 
of co - crystals of IBU - NA and CBZ - NA has been confirmed by analyzing 
their samples using DSC. Differences between samples of dilutions of IBU 
with IBU - NA co - crystals and samples of dilutions of CBZ with CBZ - NA co 
- crystals has been studied by DSC and from enthalpy values obtained from 
DSC, calibration curve has been generated which further compared with 
43 
 
Raman spectroscopic results for understanding sensitivity of analytical 
methods.  
3.2. Rheology 
3.2.1. General Introduction 
Rheology is the science of deformation and flow (rheo = river in Greek). 
Rheological experiments not only reveal information about the flow behavior 
of liquids but also the deformation behavior of solids. Rheometry is the 
measuring technology used to determine rheological data. Both liquids and 
solids can be investigated using rotational and oscillatory rheometers. To 
characterize viscous behavior rotational tests are performed while to 
evaluate viscoelastic behavior creep tests, relaxation tests and oscillatory 
tests are performed (Mezger, 2006).  A typical rheometer is shown in Fig.3.7. 
 
 
                Fig. 3.7.  Rheometer (Anton-Paar Physica MCR 301) 
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3.2.2. Viscoelasticity  
Viscoelasticity is the property of a material to exhibit viscous and elastic 
behavior simultaneously. Viscoelastic materials tend to show delayed 
response on application and removal of load. For practical applications, 
viscous and elastic portions of a viscoelastic material are required to be in a 
balanced ratio. 
Viscoelastic (VE) liquids:  VE liquids tend to deform to a certain extent after 
release of this load. Examples of VE liquids include polymer melts and 
concentrated polymer solutions. 
Viscoelastic solids: Complete reformation occurs in case of VE solids during 
prolonged testing periods. Examples of VE solids include gels, chemically 
cross-linked materials, concentrate dispersions etc. (Mezger, 2006). 
3.2.3. Significance of rheology for pharmaceutics 
When a polymer and a drug form a single phase at the processing 
temperature, not only can a more uniform product can be obtained, it may 
also lead to other desirable product properties such as faster drug dissolution 
rate. Having rheological data can minimise the time for trial and error 
experiments and help to understand a drug’s physical state during a hot melt 
extrusion (HME) process. Hence, for HME, the study of rheology is of great 
importance since it affects the processing conditions and end properties of 
the pharmaceutical products (Coates, 1995). Oscillatory tests are used to 
examine all kinds of viscoelastic materials, from low viscosity liquids to 
polymer solutions and melts, pastes, gels, elastomers and even rigid solids. 
This final mode of testing is referred to as dynamic mechanical analysis 
(DMA) (Mezger, 2006). 
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Viscosity is termed as the ratio of applied shear stress and shear rate. 
Shear stress = Applied force (F) ÷ Area 
Viscosity = Shear rate ÷ Shear stress 
Further terms are used in discussions of the rheology of complex viscoelastic 
materials and brief explanations of these are given below: 
The elastic (storage) modulus (G’) is a measure of elasticity of material which 
describes the ability of the material to store energy. In contrast the viscous 
(loss) modulus (G”) describes the ability of the material to dissipate energy. 
In addition, the ratio of these moduli is known as the damping factor and is 
denoted as the tangent of the phase angle (Tan ) (Breitkreutz et al., 2003). 
Tan = G" ÷ G′ 
3.2.4. Plasticisation effect 
The role of plasticisers is to improve the processability of polymers by 
lowering the glass transition temperature and the viscosity of the formulation 
(Rosen, 1993). 
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Fig. 3.8. Plasticisation effect (Schmeling et al., 2010). 
Fig.3.8. shows plasticization effect in polymers. Different plasticisers can be 
used for pharmaceutical formulations dependent on solubility and glass 
transition temperature.  Pharmaceutically used plasticisers are classified as 
hydrophilic or hydrophobic - typical materials being included in Table 3.1. In 
this project Triethyl Citrate has been used as a plasticizer in the preparation 
of solid dispersions of CBZ - Kollidon VA64.  
Hydrophilic Hydrophobic 
Glycerin Acetyl Tributyl Citrate 
Polyethylene Glycols Acetyl Triethyl Citrate 
Polyethylene Glycol 
Monomethyl Ether 
Castor Oil 
Propylene Glycol Phthalate Triacetin 
Sorbitol Sorbitan Solution Triethyl Citrate 
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Table 3.1. List of plasticisers (USP).  
It should be noted that a lot of APIs also can cause plasticisation when 
compounded with pharmaceutical polymers leading to a beneficial reduction 
in the viscosity of the formulation during processing. 
In this project rheological measurements have been used for preliminary 
thermal stability testing including effect of temperature and shear on the 
materials to be used. Rheological study of polymers - Kollidon VA64, 
Kollidon SR and Soluplus for confirmation of their suitability to be used for 
hot melt extrusion for the preparation of solid dispersions has been carried 
out. Along with these tests, rheological testing of CBZ has been carried out 
by making its 5%, 10%, 20% and 30% physical mixtures with Kollidon VA64 
(after finding suitability of Kollidon VA64 over Kollidon SR) to find out impact  
of drug loading on the formulations to understand and confirm plasticization 
effect of API in a formulation. 
3.3. X-ray diffraction (XRD)  
XRD is a non - destructive technique for the qualitative and quantitative 
analysis of crystalline or semi-crystalline materials, in either powder or solid 
forms. A characteristic fingerprint region in the diffraction pattern of the 
material stands for crystallinity property. To detect amorphous and crystalline 
forms of solid dispersions XRD can be used, but there is a limitation to XRD 
detection in terms of absolute crystallinity.  
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Fig. 3.9. Bragg’s Law  
XRD is obtained as the "reflection" of an X - ray beam from a family of 
parallel and equally spaced atomic planes, following Bragg's law (fig.3.9.). 
When a monochromatic X - ray beam with wavelength λ is incident on lattice 
planes with an angle θ, diffraction occurs if the path of rays reflected by 
successive planes (with distance d) is a multiple of the wavelength (GNR, 
2013), i.e.: 
2𝑑𝑠𝑖𝑛𝜃 = 𝜆 
In this project PXRD has been utilised for determination of crystallinity of 
CBZ in the solid dispersions of CBZ + Kollidon VA64 and CBZ + Soluplus. 
Purity of co - crystals of IBU - NA and determination of purity of ibuprofen in 
dilutions of IBU-Na co-crystals with ibuprofen has been studied using PXRD. 
3.4. Hot Stage Microscopy (HSM) 
Hot stage microscopy is an analytical technique which involves microscopy 
and thermal analysis to characterise physical properties of materials with 
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temperature. In the pharmaceutical field, hot stage microscopy is used to 
characterise solid-state of pharmaceuticals crystal forms and hydrates as 
well as other physical properties (Vitez et al., 1998 ). 
 
 
Fig.3.10. Hot Stage Microscope (Axiovision) 
In this project HSM has been used for understanding thermal behaviour 
(melting, degradation due to temperature) of CBZ and its polymorphic form 
transformation as well as for studying thermal stability of Soluplus prior to its 
use for hot melt extrusion.  
3.5. High performance liquid chromatography (HPLC) 
In chromatography, separation of components of a mixture between two 
phases by allowing distribution of components is carried out. High 
Performance Liquid Chromatography (HPLC) is an important analytical 
technique for separation of components and can be used to determine 
impurities in pharmaceutical formulations. 
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In HPLC a liquid mobile phase is used to transport the analytes (samples to 
be analysed) through column packed with stationary phase) (Sabir et al., 
2013). The stationary phase consists of materials with different 
hydrophobicity chemically bonded to a solid support. It is a highly selective 
technique since the analyte has the ability to interact with the mobile and 
stationary phases.  
 
 
Fig. 3.11. Waters Alliance e 2695 HPLC system 
During HPLC process, a mobile phase at fixed flow rate is pumped through 
the system by the aid of pump. Samples to be analysed are injected into the 
mobile phase without introducing air. The component mixture is carried to the 
top of the column in a narrow band.  
During this project HPLC has been used for simultaneous estimation of CBZ 
and Iminostilbene. 
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3.6. Microwave assisted synthesis 
 
Fig. 3.12. Monowave 300 synthesis reactor (Anton Paar, 2015). 
Microwave synthesis has been used in pharmaceutical industry and it is one 
of the efficient and time - saving techniques over the conventional synthesis 
methods. Due to the microwave radiations used, it reduces time of chemical 
reactions. An optional immersing ruby thermometer for precise control of 
reaction temperature is an important feature of this reactor. Heating with 
holding time and cooling of the samples can be carried out using this reactor 
which helps in changing parameters for studying effect of change in 
temperature and holding time on the samples. 
During this project the microwave reactor has been used for preparation of 
batches of IBU - NA co - crystals using various parameters such as 
temperature, holding and cooling time for getting pure co - crystals.  
3.7 Fourier Transform Infrared (FTIR) spectroscopy  
Fourier Transform Infrared (FTIR) spectroscopy is non - destructive 
analytical technique used to study various kinds of molecules (Glassford, 
2013). 
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Region Wavelength (λ) 
(µm) 
Wavenumbers 
( cm-1) 
Near 0.78 to 2.5 12800 to 4000 
Middle 2.5 to 50 4000 to 200 
Far 50 to 1000 200 to 10 
 
Table 3.2. IR spectral regions table (Skoog et al., 2007). 
Infrared spectroscopy is often described by the wavelength of the excitation 
light and is commonly denoted as Near, Mid and Far infrared spectroscopies 
according to the approximate table given in Table 3.2. 
FTIR has been widely used in the polymer and pharmaceutical industrial 
research owing to its ability to characterize materials based on functional 
groups present in their chemical structures. It is a structure elucidation 
analytical technique which generates spectra of absorption frequencies 
which stand for particular functional groups in the molecules under 
examination. Its operational mechanism involves dipole moment changes 
during vibrations and rotations of molecules. For absorption of IR radiation, a 
molecule needs to undergo a net change in dipole moment during its 
complete vibration or rotation. Because of this only, interaction of molecule 
with alternating electric field of the radiation can occur. On vibration of 
homonuclear species such as O2, N2 or Cl2 no net change takes place in 
dipole moment due to which these types of compounds are unable to absorb 
IR radiations. All other molecules can absorb IR radiation except these 
compounds (Skoog et al., 2007). 
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FTIR is a vibrational molecular spectroscopy which involves absorption of 
light and based on the difference in functional groups of chemical structures 
of the molecules, peaks at different absorption frequencies appear in the 
spectra. Two main types of vibrations occur between the molecules as 
follows: 
Stretching vibrations: These involve continuous change in the interatomic 
distance along the axis of bond between two atoms.  
Bending vibrations: These vibrations exhibit change in the angle between 
two bonds and are of four types (Fig. 3.13). 
 
Fig.  3.13. Stretching and Bending vibrations (Shodor, 2015). 
 
Dispersive spectrophotometers have a grating monochromator whereas   
Fourier transform spectrometers have an interferometer. Dispersive 
spectrophotometers were used widely until the 1980s, but these have been 
displaced by Fourier transform spectrometers for mid and far IR analysis due 
to their higher speeds, reliability and signal to noise advantage since more 
energy throughput is provided by the optics in FT instruments than that of 
dispersive ones Non - dispersive photometers using a filter or an absorbing 
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gas are used for analysis of atmospheric gases at specific wavelengths 
(Skoog et al., 2007).  
 
Fig. 3.14. Nicolet iS50 FTIR by Thermo Scientific (Thermoscientific). 
Fourier Transform Infrared (FTIR) spectroscopy is a vibrational spectroscopic 
technique which involves measurement of wavelength and intensity of the 
absorption of infrared radiations by a sample. The Nicolet iS50 FTIR used in 
the current project can work in a number of modes however for the work 
reported in this thesis it was run in Attenuated Total Reflection (ATR) mode.  
In this project FTIR has been used for characterization of SDs of CBZ - 
VA64. From the FTIR spectra of IBU - NA co-crystals and that of CBZ - NA  
Calibration curves have been generated for quantitative analysis. 
3.8. Raman Spectroscopy 
As discussed in chapter 1 Raman spectroscopy is a technique which 
involves molecular vibrations based on inelastic scattering of light by 
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molecules. Raman effect is the basic principle behind this technique which 
can be illustrated with the example from nature and reason behind blue 
colour of the sky. 
 
Fig.3.15. The Blue mystery and Raman effect (Barman, 2013). 
When water molecules in sea use white Sun - light and scatter it into the 
wavelength which falls in region which is blue in colour due to which Sky look 
blue and as its reflection sea also appear blue in colour (Fig.3.15).  
The rationale behind this effect can be understood by the fact that Rayleigh 
scattering is an elastic scattering, in which light just get deflected after 
confronting a molecule without changing its wavelength while because of 
vibrational modes of a molecules there could be inelastic scattering 
processes in case of Raman spectroscopy.  
Some terms related with Raman spectroscopy are defined below: 
Stokes and anti - Stokes scattering: When the scattered radiation’s 
frequency is lower than that of the excitation radiation, it is known as Stokes 
scattering while when frequency of scattered radiation is higher than the 
source radiation, it is known as anti - Stokes scattering. 
Rayleigh scattering: When the frequency of scattered radiation and source 
radiation is equal it is termed as Rayleigh scattering (Skoog et al., 2007). 
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3.8.1. Raman spectrophotometer instrument calibration (using 
universal platform) 
Wavelength (780nm full range grating), Neon lamp, Laser and white light 
have been calibrated during Raman spectrophotometer instrument 
calibration.  
Fluorescence reduction 
To get Raman spectra of good quality without noise various parameters such 
as Laser power, baseline correction, change in aperture slit size, exposure 
time has been carried out. Various parameters in experimental set up have 
been tried to get fine Raman spectra and to reduce fluorescence.  
1. Laser power: Laser power of 10mW, 25mW, 40mW, 50mW, 60mW, 
70mW, 80mW and 100mW have been tried to find out the difference in noise 
and quality of Raman spectra. Better spectra were obtained with 80mW and 
100mW compared to less laser powers.  
2. Baseline: Correction in fluorescence was found to give clear baselines. 
3. Aperture size: With 25µm slit aperture less noisy spectra were obtained 
than that of pinhole aperture.  
4. Containers: Transparent containers (plastic self-sealing pouches) have 
no role in showing fluorescence while glass containers were found to 
fluorescent. 
5. Exposure time: Raman spectra were obtained with various exposure 
times (10s, 20s, 30s, 40s, 60s, and 120s). It has been observed that 
increase in exposure time tends to show CCD overflow, increase in 
fluorescence and sample heating in some cases. 
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6. Photo bleaching time: Photo bleaching time of 0.5 to 5 min has been 
tried which did not reduce the fluorescence. Along with fluorescence, these 
Raman spectra were found to show signs of photo bleaching. 
Raman spectroscopic analysis of Carbamazepine with calibrated instrument 
has been carried out.  At 80mW laser power it has shown fine spectra. In 
case of solid dispersions, Raman spectra of 5% and 10% solid dispersions 
did not show fluorescence while that of 20% and 30% solid dispersions have 
shown presence of fluorescence which may indicate impact of more 
concentration of drug on fluorescence. With calibrated universal platform fine 
Polystyrene spectrum has been obtained (Fig.3.16.) which shown 
resemblance with that of standard Polystyrene spectrum by McCreery 
Research Group (McCreery, 2000). Raman shift values have been listed in 
Table 3.3. 
 
Fig. 3.16. Raman spectrum of Polystyrene  
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Raman 
shift 
(cm-1) 
Intensity 
 
  
620.38 298.810  
795.52 211.018  
1001.25 2026.643 
1031.20 539.725 
1155.03 220.788  
1182.21 300.972  
 
Table no. 3.3. Raman shift values in the Raman spectrum of 
Polystyrene 
3.8.2. Raman Spectroscopy - Instrumentation (off - line) Universal 
platform (ups) of DXR smart Raman spectrophotometer has been used for 
off - line Raman spectroscopy by placing samples in transparent container 
on the platform which covers the area where laser spot is located for laser 
radiation after placing the sample.  
 
Fig. 3.17. DXR smart Raman spectrophotometer (ups) 
59 
 
Specifications of DXR Raman spectrophotometer:   
Laser: Visible/Invisible laser radiation Max laser o/p 300mW, 25mW, 35mW 
Wavelength: 785nm, 532nm and 633nm 
Class 3B laser product. 
3.8.3. Raman spectroscopy - Instrumentation (in - line) 
A schematic of Process Raman probe used for In-line monitoring by 
Inphotonics can be seen in Fig. 3.18.  
 
 
Fig. 3.18. Schematic of Process Raman probe used for In-line 
monitoring - Inphotonics 
 
 
(a) 
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(b) 
Fig. 3.19.a) In- line Raman spectroscopic monitoring during 
pharmaceutical HME b) Process Raman probe connected to the 
extruder die 
Fig.3.19.a. and Fig.3.19.b show in-line Raman process Raman probe 
arrangement with hot melt extruder used in the present work during 
monitoring preparation of solid dispersions.  
Specifications of Process Raman probe:  
Excitation wavelength: 785nm 
Excitation fibres: 100µm core with SMA connector 
Collection fibres: 200µm with SMA connector 
Sleeve material: 326 Stainless steel with Dynisco fitting 
Window type: Sapphire (flat) 
Pressure rating: 3000psi 
Temperature rating: 204°C 
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Fig. 3.20.  Process Raman Probe – Inphotonics 
 
 
Fig.3.21. Process Raman probe fibers arrangement 
Inphotonics Process Raman probe (Model number - RPP785/12-5, Serial 
number - 332614) showed in Fig. 3.20.  has been used in this project for in - 
line monitoring of solid dispersions of CBZ + Soluplus. Arrangement of fibers 
used in connecting Process Raman probe with the laser path (to DXR smart 
Raman spectrophotometer) and Raman scattering path can be seen in Fig. 
3.21. Details of the methods and results are discussed in Chapter 4 and 5. 
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Chapter 4 - Materials and Methods 
4.1. Introduction 
This thesis consists of four parts of research work and materials and 
methods for each part are covered individually prior to the results and 
discussion for each being provided in chapter 5. These parts have been 
divided as follows: 
4.2.1 Preparation and characterisation of solid dispersions of 
Carbamazepine (CBZ) and Kollidon VA64 
4.2.2. Preparation and characterisation of solid dispersions of 
Carbamazepine and Soluplus 
4.2.3. Preparation and characterization of co-crystals of Ibuprofen (IBU) and 
Nicotinamide (NA) 
4.2.4. Preparation and characterization of co-crystals of Carbamazepine 
(CBZ) and Nicotinamide (NA) 
4.2.1. Preparation and characterisation of solid dispersions of 
Carbamazepine (CBZ) and Kollidon VA64 
Materials   
A variety of polymers, excipients and Active Pharmaceutical Ingredients 
(APIs) have been utilised throughout the project. This section briefly 
describes their chemistry and key physical properties. 
Active Pharmaceutical Ingredients 
Carbamazepine (CBZ) (DrugBank, 2005) – CBZ in polymorphic form III (p-
monoclinic) purchased from Jay Radhe Sales, Ahmadabad, India. 
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Fig.  4.1. Chemical structure of CBZ (Chem draw). 
Chemical name: (5H-dibenz (b, f) azepine-5-carboxamide (Strachan et al., 
2004). 
Chemical class: Dibenzazepine (with two benzene rings fused to an azepine 
group - unsaturated heterocycles of seven atoms, with a nitrogen replacing 
a carbon at one position.  
Therapeutic class: Anticonvulsant 
Physical characteristics: White to off-white, practically insoluble in water and 
soluble in alcohol and in acetone. Its molecular weight is 236.27g/mol. and 
its melting point is reported as being between 190 - 193°C. 
Polymorphism: CBZ is known to exist in four anhydrous polymorph forms: 
Triclinic (Form I), Trigonal (Form II), P-monoclinic (Form III) and C-
monoclinic (Form IV) as well as a dihydrate. A primitive monoclinic 
polymorph was the first to be structurally defined by x-ray analysis. A triclinic 
polymorph has also been characterized (Ceolin et al., 1997). The 
nomenclature of these polymorphs has varied between papers. Designation 
of the characterized p-monoclinic polymorph as form III and the triclinic 
polymorph as form I appear to be the most common system. Form III is 
stable at ambient temperature. The polymorphs and hydrate of CBZ have 
been shown to exhibit different dissolution rates and bioavailabilities 
(Kobayashi et al., 2000) and different commercial brands of CBZ tablets 
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have a history of bioinequivalence and clinical failure which may be due to 
polymorphism (Meyer et al., 1992). Hence CBZ is one example of a drug that 
illustrates the necessity to identify, monitor and understand pharmaceutical 
polymorphs as fully as possible. 
Order of stability: form III > form I > form IV > form II 
Form III is the commercial form. Form I is obtained by heating Form III and 
Form II, is crystallised from ethanolic solution (DrugBank, 2005). 
Polymers 
Kollidon SR 
This material was provided by BASF, Germany as a gift sample. 
BASF’s Kollidon SR (BASF, 2011) is polyvinyl acetate and povidone based 
matrix retarding agent. It contains 80% polyvinyl acetate and 19% povidone 
Ph. Eur./ USP (Kollidon 30) in a physical mixture. 
Solubility: Insoluble in water (The povidone part is soluble but the polyvinyl 
acetate part is insoluble).  
Molecular weight: (Average) of polyvinyl acetate part: 4,50,000 Da. 
One of the povidone K30 part: 50,000 Da. 
Glass transition temperature (Tg): 39°C/ 152 °C. 
Kollidon VA64 (Vinylpyrrolidon-vinylacetate copolymer)  
This material was provided by BASF, Germany as a gift sample. 
 
Fig. 4.2. Chemical structure of Kollidon VA64 (BASF) 
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BASF’s Kollidon VA64 (BASF, 2011) is a mixture of 6 parts of N-vinyl 
pyrrolidone and 4 parts of vinyl acetate.  
Solubility: Vinyl pyrrolidone is a hydrophilic, water soluble monomer whereas 
vinyl acetate is lipophilic and water insoluble. The ratio of both monomers is 
balanced in such way that the polymer is still freely water soluble. Due to 
solubility in all hydrophilic media, the release profile is mostly instant. 
Molecular weight: 45,000 -70,000 Da. 
Glass transition temperature (Tg): 107°C. 
Thermal stability: Up to 150°C. 
Sample preparation: Physical mixtures of accurately weighed drug and 
polymer were prepared by mixing the drug and polymer using a glass mortar 
and pestle in various concentrations of 5%, 10%, 20% and 30% w/w CBZ.  
TGA studies: 2 - 5mg of solid dispersions of the various concentrations 
were ground using a mortar and pestle. Samples were transferred to 
platinum crucubles for analysis. Taring of balance has been carried out prior 
to running the tests. TGA results were obtained in the range of 40 - 250°C 
using TA Instruments Universal Analysis 2000 software coupled to a TA 
Instruments Q500 Analyser. 
DSC studies: Thermal profiles were generated in the range of 40 - 250°C 
with the heating rate of 10°C / minute using a Q2000 calorimeter from TA 
Instruments. Temperature calibration was performed using an indium metal 
standard supplied with the instrument at the respective heating rate. 
Accurately weighed samples (3 - 5mg) were placed in aluminium pans using 
similar empty pans as a reference. Measurements were carried out in an 
inert atmosphere by purging nitrogen gas at the flow rate of 50 mL/min. The 
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acquired thermograms were analysed with TA Instruments Universal 
Analysis 2000 software. 
Rheological studies: Rheological characterisation of all samples were 
conducted using an Anton-Paar MCR 301 rheometer with plate-plate 
geometry with the diameter of the plate being 25 mm and a gap size of 1 
mm. Calibration for zero gap and normal force were performed prior to its 
operation in the oscillatory mode. Preliminary analysis of results was 
performed using RheoPlus software (Anton-Paar). 
Amplitude sweep: In order to establish the extent of the linear visco-elastic 
region (LVR) an oscillatory amplitude sweep was conducted over the strain 
range of 0.01 to 100 % at a constant angular frequency of 10 rad/s. The 
effect of stress on the elastic (G’) and viscous moduli (G’’) were monitored 
and a suitable value of the strain for the frequency sweeps was determined. 
Frequency sweep: Samples were exposed to angular frequencies in the 
range 0.1 to 100 rad/s at a constant strain of 3%, this value having been 
determined as being suitable by the preceding amplitude sweep. The effect 
of shear rate on elastic (G’) and viscous moduli (G’’) and complex viscosity 
was determined at temperatures of 145,150 and 155°C.  
Raman spectroscopic studies: Off-line Raman analysis of CBZ, Kollidon 
VA64 and physical mixtures of CBZ and Kollidon VA64 was carried out by 
placing samples in transparent containers on the Universal Platform of the 
Thermo Scientific DXR Smart Raman spectrophotometer after calibration 
and background corrections in the wavenumber range of 200 - 3500cm-1. 
Raman spectra were converted into Grams format for interpretation using 
Grams 9.1 spectroscopy software (Thermo Fisher Scientific Inc.). The 785 
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nm laser power was set at 80mW with a warm up time of 5 minutes. 32 
scans of 10 seconds duration were taken for each sample. For each scan 
approximately 11.25 seconds was required. 
Hot melt extrusion: Solid dispersions were prepared by the hot melt 
extrusion method using physical mixtures of various concentrations as 5%, 
10%, 20%, 30% and 40%. Prior to extrusion, CBZ and Kollidon VA64 were 
ground properly using mortar and pestle in predefined weight ratios. The 
powder blends were fed from a gravimetric twin screw feeder (Brabender, 
Germany) into the Pharmalab 16 Twin screw Extruder (Thermo Scientific, 
UK) using a calibrated feed rate of 0.25 kg/hr and the extruder was 
continuously run at a set screw speed of 25rpm. The extruder is a 16mm 
diameter co-rotating twin screw extruder with screw length to diameter ratio 
of 40.The temperature profile maintained along the length of the barrel is 
shown in Table 4.1 and the modular screw design is summarised in Table 
4.2.  
 
 Zone 
T (°C) Die 10 9 8 7 6 5 4 3 2 
A-1 140 140 140 130 120 110 110 100 90 50 
 
Table 4.1. Temperature profile (°C) along extruder barrel 
 
Pharma 4 screw configuration used for HME 
No. of elements Type of element 
28 Forward conveying 
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9 30o forward mixing 
5 60o forward mixing 
4 90o mixing 
6 Forward conveying 
1 Discharge 
 
Table 4.2. Pharma 4 screw configuration used for HME 
 
Fig. 4.3. Types of screw elements used for HME 
The prepared solid dispersions were subjected to off-line Raman analysis at 
the same settings discussed above for the physical mixtures of CBZ and 
Kollidon VA64. 
 
XRD analysis: The crystal structure of the solid dispersions was determined 
by X-ray powder diffraction using a Bruker D8 diffractometer (wavelength of 
X-rays 0.154 nm from a Cu source, voltage 40 keV, and filament emission 40 
mA). Samples were scanned in the range of 2 to 40° (2θ) using a 0.01° step 
width and a 1 second time count. The receiving slit was set to 1° and the 
scatter slit to 0.2°. 
FTIR studies: FTIR studies of CBZ, Kollidon VA64 and SDs in the various 
concentrations (5%, 10%, 20%, and 30%) were carried out by using a Digilab 
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FTIR microscope. Backgrounds were collected before the actual spectra with 
16 scans each. FTIR spectra were obtained using Digilab Merlin software. 
4.2.2. Preparation and characterisation of solid dispersions of 
Carbamazepine and Soluplus 
Materials 
Soluplus 
This polymer was provided by BASF, Germany as a gift sample. Soluplus 
(BASF, 2011) is a polyvinyl caprolactam - polyvinyl acetate - polyethylene 
glycol graft copolymer. It is a polymeric solubiliser with amphiphilic chemical 
structure. Since it is bifunctional in nature, it can be used as a matrix polymer 
for solid solutions as well as an aid for solubilising poorly soluble drugs in 
aqueous media. 
It is a free flowing white to slightly yellowish granule without taste. It can 
increase solubility and bioavailability of poorly soluble drugs. For hot melt 
extrusion, it has been found as an ideal candidate due to its excellent 
extrudability and easy processing.  
 
 
 Fig. 4.4. Chemical structure of Soluplus (BASF)  
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Glass transition temperature (Tg): Approximately 70°C 
Solubility: Soluble in water, soluble in acetone (up to 50%), methanol (up to 
45%), ethanol (up to 25%) and dimethylformamide (up to 50%) 
Molecular weight: 90,000-1, 40,000 g/mol.  
Extrusion recommendations: Pure polymer can be extruded on a 16mm twin 
screw extruder at temperatures starting around 120˚C to 180˚C depending 
upon the applied screw configuration. The polymer shows no chemical 
degradation even after extrusion at 180˚C. Incorporation of a drug can lead 
to lower temperatures than 120˚C in dependence on the drug melting point. 
Solid dispersions of Carbamazepine (CBZ) (5H-dibenzo [b, f] azepine-5-
carboxamide) and Soluplus were prepared by a hot melt extrusion process 
using a twin screw extruder at a screw speed of 30rpm and at temperatures 
in the range of 120 to 170˚C using two temperature profiles T1 and T2 and a 
feed rate of 0.18 kg/hr.(Table 4.3). A comparative study of Raman spectra of 
extrudates with that of metabolite of carbamazepine, 5H-Dibenz (b, f) 
azepine (Iminostilbene) was carried out. In-line Raman spectroscopic 
analysis of Carbamazepine, Soluplus and solid dispersions of 
Carbamazepine-Soluplus (5, 10, 20, and 30%) has been carried out using 
Inphotonics Raman probe with 80mW laser power and 2 scans of 60s 
acquisition. A series of spectra was collected using with OMNIC software. 
Spectra were converted into Grams format using Grams 9.1 by 
ThermoScientific.  
 Zone 
 Die 10 9 8 7 6 5 4 3 2 
T1 (°C) 170 170 170 150 150 150 140 140 140 130 
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T2 °C) 170 160 160 160 150 140 120 120 120 120 
 
Table 4.3. Temperature profiles used during hot melt extrusion 
DSC analysis of CBZ, Soluplus and CBZ-Soluplus physical mixtures was 
carried out using a similar method to that described in section 4.2.1. Physical 
mixtures were prepared by using mortar and pestle in concentrations 5, 10, 
20 and 30%w/w. Thermal profiles were generated in the range of 20˚C - 
220˚C at a heating rate of 10˚C per minute.  
XRD and off-line Raman analyses of base materials, physical mixtures and 
solid dispersions were carried out using the same methods as for section 
4.2.1. Two scans of 120 seconds were taken for the off-line Raman using 
80mW laser power. 
Additionally samples were subjected to hot stage microscopic analysis 
(HSM) utilizing Axiovision software connected to Linksys 32 software with a 
Linkam hot stage attached to a microscope. 
Small amount of samples (2-3mg) were placed on open glass slides fixed 
onto the hot stage with 10x/0.20 magnification with bifocal light and heated 
form 30°C to 220°C at 10°C per minute. 
4.2.3. Preparation and characterization of co-crystals of Ibuprofen (IBU) 
and Nicotinamide (NA) 
Materials: 
Ibuprofen (Wishart DS et al., 2006). 
This material was purchased from Albemarle, USA. 
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Fig. 4.5. Chemical structure of Ibuprofen (Chem draw) 
IUPAC name: (RS)-2-(4-(2-methylpropyl) phenyl) propanoic acid 
Therapeutic class: nonsteroidal anti-inflammatory drug (NSAID) 
Molecular formula: C13H18O2 
Molecular mass: 206.29g/mol 
Density: 1.03g/ml/ g/cm3 
Melting point: 75 to 78°C 
Nicotinamide (Wishart DS et al., 2006). 
This material was purchased from Fluka analytical - SIGMA - ALDRICH - 
GmbH, Steinheim. 
 
Fig.4.6. Chemical structure of Nicotinamide (Chem draw) 
IUPAC name: pyridine-3-carboxamide 
Therapeutic class: a water-soluble vitamin and is part of the vitamin B group.  
Molecular formula: C6H6N2O 
Molecular mass: 122.12g/mol 
Density: 1.4463g/cm3 
Melting point: 129.5°C 
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Two methods of preparation of Ibuprofen-Nicotinamide co - crystals were 
investigated in this study: 
a) Preparation by solvent evaporation using a method reported in the recent 
literature (Soares and Carneiro, 2013) and, 
b) Preparation by solvent mediated co - crystallisation using a microwave 
reactor. 
a) Preparation of IBU - NA co - crystals by solvent evaporation: 
3 mmol of ibuprofen (618.8 mg) and 3 mmol of nicotinamide (366.4 mg) were 
placed in a beaker and dissolved in 3 ml of methanol. After 10 - 12 hours, co-
crystals were obtained on complete evaporation of the solvent. For complete 
removal of residual moisture, the resultant co-crystals were heated in an 
oven at 40°C for more than 12 hours. The purity of the produced co-crystals 
was established using DSC and XRD techniques. Preparation of physical 
mixtures of pure Ibuprofen and co-crystals of Ibuprofen and Nicotinamide in 
various concentrations (Table 4.4.) was carried out.  
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Sample name 
 
% of  pure Ibuprofen 
 
% of IBU-NA co-
crystals  
CC1 10 90 
CC2 20 80 
CC3 30 70 
CC4 40 60 
CC5 50 50 
CC6 60 40 
CC7 70 30 
CC8 80 20 
CC9 90 10 
 
Table 4.4. Concentrations of physical mixtures of Ibuprofen and co-
crystals of Ibuprofen and Nicotinamide 
Crystallinity of co - crystals along with pure Ibuprofen and Nicotinamide was 
determined by powder X - ray powder diffraction using the same methods for 
solid dispersions described earlier (under section 4.2.1. methods). 
 
b) Preparation of IBU - NA co-crystals by microwave - reactor method: 
Ibuprofen and Nicotinamide in molar ratio (1:1) were mixed with 82µL of 
distilled water and added in 30 mL capacity glass tube. The initial 
temperature chosen was 70°C and samples were subjected to microwave 
irradiation with the holding time of 1 minute and cooled at 40°C for 1 minute. 
Various batches of co-crystals were prepared to get pure co-crystals with 
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different holding times and temperatures during microwave preparation as 
mentioned in the table 4.5. The obtained IBU-NA co-crystals were analysed 
by DSC and XRD. 
Batch name Heating 
temperature 
(°C) 
Holding 
time  
(min) 
Cooling 
temperature 
 (°C) 
C1 70 1 40 
C2 70 2 40 
C3 70 3 40 
C4 75 1 40 
C5 75 2 40 
C6 75 3 40 
C7 80 1 40 
C8 80 2 40 
C9 80 3 40 
C10 70 5 40 
C11 75 5 40 
C12 80 5 40 
C13 70 5 40 
C14 75 5 0 
C15 80 5 40 
A,B,C,D,E 80 5 40 
     
Table 4.5. Microwave preparation parameters during preparation 
Ibuprofen-Nicotinamide co-crystals. 
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Thermal profiles from DSC were generated in the range of 40 – 170°C using 
a Q2000 calorimeter from TA Instruments. Accurately weighed samples (3-
5mg) were placed in aluminium pans using similar empty pans as a 
reference. A heating rate of 10°C per minute was employed.  
The diffractograms of co-crystals along with pure Ibuprofen and Nicotinamide 
has been determined by X-ray powder diffraction using the techniques 
described above. 
Offline Raman spectroscopic analysis of all physical mixtures (CC1 to CC9) 
along with %age co-crystals (Ibuprofen-Nicotinamide physical mixture 1:1) 
and 100% pure co-crystals was carried out using the Thermo Scientific DXR 
Smart Raman spectrometer with universal platform accessory. 
All spectra were collected using 80 mW laser power, 25 µm slit with 780 nm 
laser with estimated spot size of 3.1µm and estimated resolution of 5.0 to 
9.2cm-1. 2 scans of 60s acquisition each were collected. A new chemometric 
method was created for preparing calibration curve for prediction of 
concentration of Ibuprofen and co-crystals of Ibuprofen and Nicotinamide 
using the software TQ Analyst 8 by Thermoscientific. A Partial Least Squares 
(PLS) method was selected with standard normal variate and second 
derivative spectra were selected for the study. 
In addition, FTIR analysis of Ibuprofen-Nicotinamide (IBU - NA) co-crystal 
dilutions with Ibuprofen (10-100%) was carried out using Nicolet is50 ATR 
FTIR by Thermoscientific. Samples were analysed at 32 scans with 4cm-1 
resolution and calibration curves generated from FTIR spectra using the 
software TQ Analyst and Microsoft excel. 
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4.2.4. Preparation and characterization of co-crystals of 
Carbamazepine (CBZ) and Nicotinamide (NA) 
A 1:1 physical mixture of Carbamazepine (2.363 g, 0.01mol) and 
Nicotinamide (1.221 g, 0.01 mol) was dissolved in 20 ml of absolute ethanol, 
heated and stirred for 30 minutes. The mixture was then left to evaporate at 
303.2 K for 72 hours for evaporation (Ali et al., 2014). Co-crystals obtained 
were dried using filter paper and characterised by DSC. 
DSC analysis of co-crystals of CBZ-Na was carried out using a Discovery 
DSC by TA Instruments. Thermal profiles were generated by using a heating 
ramp of 5°C/min in the range of 40 to 220°C. Accurately weighed samples 
(3-5mg) were placed in aluminium pans using similar empty pans as a 
reference. Measurements were carried out in an inert atmosphere by purging 
nitrogen gas at the flow rate of 50 mL/min.  
DSC profiles obtained in Trios format were exported in Microsoft excel for 
generation of a calibration curve using enthalpy values. A calibration curve 
was generated by plotting a graph of actual concentration of dilution co-
crystals with CBZ versus measured concentration of dilutions co-crystals with 
CBZ from DSC enthalpy data. 
Dilutions of co-crystals of CBZ-NA (Table 4.6.) with CBZ have been prepared 
by making physical mixtures using mortar and pestle. Off-line Raman 
spectroscopic analysis of these dilutions along with physical mixture of 
Carbamazepine and Nicotinamide (1:1) and co-crystals has been carried out 
using DXR Smart Raman spectrophotometer by Thermo Scientific. All 
spectra were collected using 80mW laser power, 25µm slit at 780nm with 2 
scans of 10 seconds acquisition each. 
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A new chemometric method was created for generating calibration curve for 
prediction of concentration of Carbamazepine and co-crystals of CBZ and Na 
using TQ Analyst 8. Partial least squares (PLS) method was selected with 
standard normal variate and second derivative spectra were selected for the 
study. Spectral data normalisation was carried out by using the mean 
centering technique.  
 
Sample name 
 
% co-crystals of CBZ-Na 
 
% of  pure CBZ 
CNA1 90 10 
CNA2 80 20 
CNA3 70 30 
CNA4 60 40 
CNA5 50 50 
CNA6 40 60 
CNA7 30 70 
CNA8 20 80 
CNA9 10 90 
 
Table 4.6. Dilutions of physical mixtures of co-crystals of CBZ and NA 
with CBZ. 
FTIR analysis of Carbamazepine-Nicotinamide (CBZ - NA) co-crystal 
dilutions with Ibuprofen (10-100%) has been carried out using Nicolet is50 
ATR FTIR by Thermoscientific. Samples have been analysed at 32 scans 
with 4cm-1 resolution. Calibration curves have been generated from FTIR 
spectra using the software TQ Analyst and Microsoft excel. 
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Chapter 5 - Results and discussion 
5.1. Introduction  
For improving solubility of pharmaceutical active ingredients and to get better 
formulations as a result, preparation of solid dispersions is a great approach. 
Carbamazepine has been selected based on its polymorphic nature to study 
its various forms and degradation due to temperature as well as impact of 
shear on it. After carrying out some literature and basic thermal 
characterization Kollidon VA64 and Soluplus have been selected as 
polymers to be used in the preparation of solid dispersions. Ibuprofen-
Nicotinamide has been used widely as a model co-crystal system which has 
been selected to be studied using Raman spectroscopy. Also in the present 
work, preparation of Ibuprofen-Nicotinamide co-crystals has been carried out 
by microwave and solvent evaporation method as well as of carbamazepine-
nicotinamide co-crystals by solvent evaporation and hot melt extrusion 
method. This chapter focusses on pharmaceutical systems used for 
proposed study including solid dispersions of Carbamazepine - Kollidon 
VA64, Carbamazepine - Soluplus and co-crystals of Ibuprofen - Nicotinamide 
and Carbamazepine- Nicotinamide. After preliminary characterization by 
DSC, TGA and PXRD, analysis of all these systems has been carried out by 
off-line and in-line methods. As mentioned in chapter 4 results and 
discussion have been described in four parts of present research work. A 
flow chart explaining contents in this chapter in precise manner is shown in 
Fig.5.1.                                                            
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Fig.5.1. Flow chart showing contents of chapter 5 
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5.2. Preparation and characterisation of solid dispersions of 
Carbamazepine (CBZ) and Kollidon VA64 
5.2.1. DSC results 
CBZ and Kollidon VA64 were analysed by DSC using TA Instruments Q2000 
to study their thermal properties for further processing. Solid dispersions of 
different concentrations of CBZ (5%, 10%, 20%, and 30%) and pure Kollidon 
VA64 were prepared by HME. DSC thermo grams of these solid dispersions 
were obtained by the same method and difference between thermal 
properties of API, polymer and solid dispersions was studied. 
 
Fig.5.2. DSC profile of CBZ 
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Fig.5.3. DSC profile of Kollidon VA64 
In the DSC profile of CBZ- commercial form two endotherms of fusion were 
observed. Melting of CBZ - III (p-monoclinic) can be seen at 177˚C (Fig. 
5.2.). An exothermic peak showing crystallization as form - I (triclinic) and its 
melting can be seen as an endothermic peak at 193˚C. DSC profile of 
Kollidon VA64 shows Tg value of 106˚C (Fig. 5.3). 
5.2.2. MDSC results  
Modulated DSC determines heat capacity and aids in separating heat flow 
due to reversible and non-reversible events. Refer back to chapter 3 - 
Experimental techniques for details describing the linear heating rate and 
amplitude and frequency of modulation. 
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Fig.5.4. MDSC profile of CBZ: Reversible heat flow  
 
Fig.5.5. MDSC profile of CBZ: Non-reversible heat flow 
MDSC analysis of Carbamazepine was carried out with heating rate of 
5˚C/min, amplitude of +/- 1 ˚C and modulation period of 60sec. From Fig.5.4. 
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and 5.5., it was observed that form 1 started melting first, and then the 
molten form got recrystallized which indicate conversion into form III.   
DSC studies of solid dispersions of various concentrations of CBZ in Kollidon 
VA64 were carried out. Results obtained from these studies indicate that an 
increase in the concentration of active pharmaceutical ingredient - 
Carbamazepine decreases the glass transition temperature of the solid 
dispersion.  
 
 
Fig.5.6. DSC profiles of CBZ - Kollidon VA64 SDs 
A melting peak can be seen in Fig. 5.6. at 170°C which can be because of 
melting of CBZ form III (p-monoclinic). 
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Fig.5.7. Plot of glass transition temperature Tg (˚C) Vs CBZ 
concentration (%) from DSC studies 
From Fig 5.7., it is observed that there is decrease in Tg value of solid 
dispersion as per increase in CBZ concentration. 
5.2.3. TGA results  
TGA was used to observe the decomposition temperature of the samples 
and to determine the moisture content of solid dispersions. The sample of 
pure CBZ was allowed to heat from 40°C to 200°C at the rate of 10°C/min.  
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Fig.5.8.TGA profiles of CBZ, Kollidon VA64, and SDs (5, 10, 
20 and 30%) 
TGA profile of Kollidon VA64 indicates presence of moisture which can be 
because of its hygroscopic nature. From the TGA profiles of solid dispersions 
(Fig. 5.8.) it can be seen that there is loss of moisture in 5% SD which is 
more than that of in 10%, 20% and 30%SDs. 
5.2.4. Preparation of different forms of Carbamazepine and 
characterization by DSC 
Carbamazepine was selected for the present study as mentioned before 
based on its polymorphic nature and after its preliminary analysis. Form I and 
dihydrate of carbamazepine have been prepared and analysed along with 
carbamazepine by DSC to find out the difference between all forms. 
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5.2.5. Preparation of Carbamazepine form I (triclinic) from form III (p-
monoclinic) 
Carbamazepine form I (triclinic) was prepared by heating commercial 
carbamazepine form III (p-monoclinic) at 170°C for 2 hrs. 
5.2.6. Preparation of Carbamazepine dihydrate  
Carbamazepine dihydrate was prepared by dissolving commercial 
Carbamazepine (4g) sample in distilled water (100mL) and kept it for stirring 
for 24 hrs. After that it was filtered using vacuum pump and dried at ambient 
temperature using filter paper (O’Brien et al., 2004). DSC profile of 
carbamazepine dihydrate exhibits a peak at 110-120°C which is absent in 
the DSC profile of commercial carbamazepine (form III). This can be seen in 
Fig.5.9.   
 
Fig.5.9. DSC profiles of CBZ form III, I and dihydrate 
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In the DSC of CBZ dihydrate there is a peak at 177˚C which may be due to 
conversion into form I and its crystallization and again melting as form - I. 
These peaks resemble those reported in the literature (O’Brien et al., 2004). 
5.2.7. Hot melt extrusion results  
Hot melt extrusion of physical mixtures of various drug concentrations as 5%, 
10%, 20%, and 30% was carried out. Extrusion of the 40% physical mixture 
was also attempted, but instead of an ‘elastic’ extrudate, it produced a liquid 
not suitable for extrusion. 5% Triethyl citrate (TEC) was used as a plasticizer 
using syringe pump ISCO model 100DX by Presearch with flow rate of 
0.2175 ml/min.  
From preliminary studies it was observed that Carbamazepine gets degraded 
above 140°C while rheology studies of Kollidon VA64 have shown it is stable 
to be up to 150°C. Based on these observations, temperature profile of 50-
140°C was selected for hot melt extrusion process (Refer back to chapter 4 - 
Materials and methods showing whole temperature profiles). 
Temperature 
profile : 
Drug concentration 
in % 
50-140°C  5 10 20 30 40 
Extrusion 
status 
     
Successful –  
Unsuccessful -
 
 
Table 5.1 HME results 
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5.2.8. Rheology results 
Rheology studies were carried out as a preliminary analysis of APIs and 
polymers. Understanding of polymer stability at high temperatures along with 
API to further process it on hot melt extruder was essential. Based on results 
obtained using rheology testing, temperature ranges to be used in hot melt 
extrusion for preparation of solid dispersions have been selected. Along with 
temperature, plasticizing effect and shear thinning behavior have been 
indicated by rheology results. 
Frequency sweeps are oscillatory tests performed at variable frequencies, 
with a strain amplitude of 3%, this having been found to be within the linear 
viscoelastic range from amplitude sweeps on the same material. Frequency 
sweeps have been used to investigate time-dependent shear behaviour 
since the frequency is the inverse of time.  
5.2.9. Polymer analysis 
Kollidon VA64 and Kollidon SR comparative study at 150°C 
Rheological analysis of Kollidon VA64 and Kollidon SR has been carried out 
to find out suitability for use in the preparation of solid dispersions. 
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Fig.5.10. a. Complex viscosity Vs angular frequency: Kollidon VA64 SR  
Kollidon VA64 exhibits much lower values of complex viscosity than Kollidon 
SR (Fig. 5.10.a.) allowing easier processing in the small twin screw extruder 
used in the present studies hence providing the rationale behind the 
selection of Kollidon VA64 over Kollidon SR for production of solid 
dispersions. 
 
Fig. 5.10.b. G’/G” Vs angular frequency: Kollidon VA64 and Kollidon SR 
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From the Fig. 5.10.b. it can be clearly seen that increases in storage and loss 
moduli for both Kollidon VA64 and Kollidon SR with increase in angular 
frequency are apparent. At high shear rates the values are very similar for 
both polymers while at low shear rate the moduli values are much lower for 
Kollidon VA64.  
From the results shown in Fig.5.10.a. and 5.10.b. it can said that Kollidon 
VA64 will be much easier to process than Kollidon SR due to its less viscous 
nature. 
5.2.10. Rheological analysis of Kollidon VA64 
Prior to formulation development, understanding of rheological properties of 
polymer to be used for the study was important. Rheological studies of 
Kollidon VA64 have been carried out to determine its thermal stability as well 
as to see effect of drug loading along with it which was significant information 
for using it on hot melt extrusions. 
Time sweep test for Kollidon has been carried out. A graph of complex 
viscosity Vs time was plotted using Kollidon VA64 data which shows thermal 
stability of Kollidon VA64 (Fig. 5.11.). 
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Fig.5.11. Time sweep test for Kollidon VA64 
 
Fig. 5.12. Time sweep test (amplitude strain = 3%) 
The plot shown in Fig. 5.12. is a time sweep which indicate that the material 
is stable in flow at this temperature even after half an hour. Since the 
material would stay at this temperature in the extruder for less than this time 
then we can say that VA64 is a stable material exhibiting little degradation.  
 
 
100
1,000
10,000
0 500 1000 1500 2000
C
o
m
p
le
x 
vi
sc
o
si
ty
 ɳ
 (
P
a.
s)
 
Time (s) 
Time sweep test - Kollidon VA64 
100
1,000
10,000
100,000
0 200 400 600 800 1000 1200 1400 1600 1800 2000St
o
ra
ge
 a
n
d
 L
o
ss
  M
o
d
u
lu
s 
(P
a)
 
Time (s) 
Time sweep test - Kollidon VA64 
Storage modulus G' Loss modulus G''
93 
 
 
5.2.11. Polymer and physical mixture analysis: study of effect of drug 
loading 
Rheological analysis of 0%, 5%, 10%, 20% and 30% CBZ-VA64 physical 
mixtures has been carried out. 
 
Fig. 5.13. Complex viscosity Vs angular frequency plot for pure 
Kollidon VA64 
 
 
Fig. 5.14. G’/G” Vs angular frequency plot for pure Kollidon VA64 
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Fig. 5.15.Tan δ Vs angular frequency plot for pure Kollidon VA64 
 
 
Fig. 5.16. 5% Complex viscosity Vs angular frequency 
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Fig. 5.17. 5% G’/G” Vs angular frequency 
 
 
 
Fig. 5.18. 5% Tan δ Vs angular frequency 
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Fig. 5.19. 10% Complex viscosity Vs angular frequency 
 
 
Fig. 5.20. 10% G’/G” Vs angular frequency 
 
 
1.00E+03
1.00E+04
1.00E+05
0.1 1 10 100
C
o
m
p
le
x 
vi
sc
o
si
ty
 (
P
a.
s)
 
Angular frequency ω (rad/s) 
10% pm of CBZ-Kollidon VA64 
T= 145°C
T = 150°C
T= 155°C
1.00E+01
1.00E+02
1.00E+03
1.00E+04
1.00E+05
1.00E+06
0.1 1 10 100St
o
ra
ge
 m
o
d
u
lu
s 
(G
')
 /
 L
o
ss
 m
o
d
u
lu
s 
(G
")
 
 
Angular frequency ω (rad/s) 
10% pm of CBZ+Kollidon VA64 
G' T=145°C"
G" T= 145°C
G' T= 150°C
G" T= 150°C
G' T= 155°C
G" T= 155°C
97 
 
 
Fig.5.21. 10% Tan δ Vs angular frequency 
 
 
 
Fig. 5.22. 20% Complex viscosity Vs angular frequency 
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Fig. 5.23. 20% G’/G” Vs angular frequency 
 
 
Fig.5.24. 20% Tan δ Vs angular frequency 
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Fig.5.25. 30% Complex viscosity Vs angular frequency 
 
 
 
Fig.5.26. 30% G’/G” Vs angular frequency 
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Fig.5.27. 30% Tan δ Vs angular frequency 
Kollidon VA64 was found to be stable at 150°C by rheology studies. It can be 
seen from the plot (Fig. 5.13.) that with increase in angular frequency, there 
is decrease in complex viscosity. It indicates that as the shear rate goes up 
(increasing angular frequency) then viscosity reduces. In Fig. 5.14. it can be 
seen that the storage and loss moduli is comparatively high at 150°C with 
increase in angular frequency than for 155°C.Damping factor Tan δ has been 
found to be reduced with an increase in angular frequency) Fig.5.15.). 
Fig. 5.16. shows reduction in complex viscosity of 5% pm of CBZ - Kollidon 
VA64 with increase in angular frequency and it is with faster rate at 145°C 
compared to 150°C while from Fig. 5.17. it can be observed that increasing 
angular frequency leads to increase in storage modulus and loss modulus 
values with higher rate at 145°C in similar way as that of with complex 
viscosity plot. 
With increase in angular frequency damping factor was found to be reduced 
with a higher rate than at 145°C in case of 5% pm of CBZ - Kollidon VA64 
(Fig.5.18.) 
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From Fig. 5.19. it can be seen that with increase in angular frequency there 
was decrease in complex viscosity in case of 10% pm of CBZ + Kollidon 
VA64 with higher rate of decrease at 145°C, 150°C and 155°C respectively. 
Results of G’ and G” and damping factor decreasing with increase in angular 
frequency in case of 10%pm of CBZ+ Kollidon VA64 can be seen in Fig.5.20. 
and Fig.5.21. respectively.  
In Fig.5.22. and 5.24. with increasing angular frequency, viscosity, storage 
modulus and loss modulus and damping factor were found to be reduced. 
Fig.5.23. shows results of storage modulus and loss modulus Vs angular 
frequency for 20%pm. Fig. 5.25., 5.26. and 5.27. indicate reduction in 
viscosity with increase in angular frequency, increase in storage and loss 
modulus with increasing angular frequency while tan δ has been found to 
decrease more rapidly with decrease in temperature as angular frequency 
increases. From all these results it can be said that Carbamazepine acts as a 
plasticizer itself. 
Rheological analysis of Kollidon VA64 - CBZ blends/physical mixtures at 
145°C have been carried out. Since Carbamazepine have reported to get 
degraded above 140°C, to study effect of drug loading and plasticizing effect 
along with polymer, 0 - 30% physical mixtures have been used for this 
analysis. 
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Fig. 5.28. Variation of complex viscosity with angular frequency for 
Kollidon VA64 / CBZ blends at 145 ̊C 
Rheology data (Fig. 5.28.) indicates that the complex viscosity decreases 
with increasing drug loading (5%, 10%, 20%, 30%) and with increase in 
angular frequency indicating a platicising effect of the drug upon the 
formulation as well as shear thinning behaviour.  
5.2.12. Raman Spectroscopy results 
The characterization of CBZ, Kollidon VA64, their physical mixtures and solid 
dispersions produced by HME was carried out by Raman spectroscopy using 
the Thermo Scientific DXR Smart Raman spectrophotometer. Raman 
spectra were converted into Grams format for interpretation using GRAMS 
9.1 spectroscopy software (Thermo Fisher Scientific). While choosing picking 
parameters, peak height thresholds of 500, 30, 25, 10 and 5 were selected 
for CBZ, 30% SD, 20% SD, 10% SD and 5% SD respectively to get desirable 
peaks. 
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Fig 5.29. Raman spectrum of CBZ (p-monoclinic form) 
 No. Raman shift (cm)-1 Functional group assignment 
1. 3065-3017 Aromatic  ν(C-H) 
2. 1617 ν(C=O) 
3. 1559-1594 ν(C-C) 
4. 1483 β(C-H) 
5. 1302 ν(C-C) 
6. 1243 β(C-H) 
7. 1215 β(N-H), β(O-H) in carboxamide gr. 
8. 1034, 1018 ν(C-C), β(N-H) in carboxamide gr. 
9. 785 β(O-H) , β(N-H), β(C-H) in 
carboxamide gr. 
10. 716 β(N-H), β(O-H) in carboxamide gr. 
11. 692 β(O-H) , β(N-H), β(C-H) in 
carboxamide gr. 
12. 537 Β(C-O) , β(N-H), β(O-H) in 
carboxamide gr. 
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Table 5. 2. Functional group assignment of Raman spectra of CBZ (p-
monoclinic form) (ν – stretching, β – bending vibrations) (Czernicki and 
Baranska, 2013). 
 
Raman spectrum of CBZ (Fig. 5.29.) showed prominent absorption bands of 
aromatic C-H stretching at 3065-3017 cm-1 and a sharp peak at 1617 cm-1 for 
the C=C stretching of the amide group. The C-C stretching vibrations 
responsible for strong peaks at 1559- 1594 cm-1 and weak peaks at 1035 
and 1018 cm-1 in carboxamide group. These characteristic peaks are found 
to be in resemblance with those reported in the literature (Czernicki and 
Baranska, 2013). 
Fig. 5.30. and 5.31. show comparison of Raman spectra of physical mixtures 
of CBZ-Kollidon VA64 and Raman spectra of CBZ-Kollidon VA64 SDs 
respectively. There was some shifting of wavenumber in the spectra as there 
might be interaction between the API and polymer. Appearance of 
characteristic peaks with reduced intensity indicates the decrease in 
crystallinity of CBZ in SDs which can be seen listed in the table 5.2. 
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Fig 5.30. Comparison of physical mixtures of CBZ and VA64 with CBZ 
 
Fig. 5.31. Comparison of solid dispersions of CBZ and Kollidon VA64 
with CBZ 
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(ν – stretching, β  - 
bending  vibrations) 
P
M 
SD PM SD PM SD PM SD 
1. 3065-
3017 
Arom
atic    
ν(C-
H) 
22
22 
   PM    
2. 1617 ν(C=
O) 
16
17 
16
13
 
161
9 
1613
 
1620 1613
 
1620 1614
 
3. 1559-
1594 
ν(C-
C) 
15
60 
15
55
 
159
6 
1590
 
1597 1590
 
1597 1591
 
4. 1483 β(C-
H) 
14
85 
14
84
 
148
6 
1483
 
1486 1483
 
1486 1482
 
5. 1302 ν(C-
C) 
13
02 
12
98
 
130
4 
1298
 
1306 1298
 
1305 1299
 
6. 1243 β(C-
H) 
- - - - - - - - 
7. 1215 β(N-
H), 
β(O-
H) in 
carbo
12
15 
12
15 
121
8 
1211
 
1218 1211
 
1218 1212
 
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xamid
e gr. 
8. 1034, 
1018 
ν(C-
C), 
β(N-
H) in 
carbo
xamid
e gr. 
10
17 
10
11
 
103
6,1
019 
1027,
1011
 
1037
,102
1 
1029,
1011
 
1037
,102
1 
1030
, 
1013
 
9. 785 β(O-
H) , 
β(N-
H), 
β(C-
H) in 
carbo
xamid
e gr. 
- - - - 787 782 788 783 
10
. 
716 β(N-
H), 
β(O-
H) in 
carbo
xamid
e gr. 
73
3 
72
9 
719 711 719 711 719 712 
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11
. 
692 β(O-
H) , 
β(N-
H), 
β(C-
H) in 
carbo
xamid
e gr. 
- - 694 - 695 - 695 688 
12
. 
537 β (C-
O) , 
β(N-
H), 
β(O-
H) in 
carbo
xamid
e gr. 
- - - - 540 - 540 538 
 
Table 5. 3.  Comparison of Raman frequencies of CBZ with physical 
mixtures and solid dispersions 
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Fig. 5.32. Differentiation between CBZ and SD by Raman Spectroscopy 
 
Fig. 5.33. Differentiation between PM (up) and SD (down) (30%) by 
Raman Spectroscopy 
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Fig.5.32. shows the difference between CBZ and SD (30%) where decrease 
in wavenumber for C-C stretching can be seen.  
Fig.5.33. shows difference between peaks of C-C stretching and N-H 
bending in case of 30% PM and 30% SD after HME. In the Raman spectra of 
5% and 10% SDs the characteristic absorption bands of CBZ were not 
prominent. The characteristic peak of CBZ might overlap between the 
absorption bands of the Kollidon VA64. While in the Raman spectra 20% and 
30% SDs the characteristic peaks of CBZ with reduced intensity can be seen 
in the region of 1600-1000 cm- which can be an indication of reduced 
crystallinity of CBZ tending towards amorphous form.  
5.2.13. Calibration curve for Carbamazepine concentration in solid 
dispersions of Carbamazepine and Kollidon VA64 from Raman 
spectroscopic results 
Calibration curve has been generated for Carbamazepine concentration in 
solid dispersions of Carbamazepine and Kollidon VA64 using the full range 
Raman spectra of 0 - 30% SDs using TQ Analyst by Thermoscientific. A 
partial least square method with 3 factors was found to give correlation 
coefficient value of 0.9844. This can be seen in Fig. 5.34.  
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Fig. 5.34. Calibration curve - CBZ concentration in CBZ - Kollidon VA64 
SDs 
This clearly shows that Raman is a suitable technique for monitoring of CBZ 
levels in solid dispersions of CBZ- Kollidon VA64. 
5.2.14. Fourier transformed infra-red spectroscopy (FTIR) results 
To further understand chemical interaction between functional groups of the 
molecules, FTIR analysis was carried out.  
Functional group assignment has been carried out based on the peaks 
corresponding to the functional groups as per FTIR values. 
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Fig.5.35. FTIR spectra of CBZ 
Sr. 
No. 
ν (cm)-1 Functional group assignment 
1. 3464        -N-H   stretching 
2. 3340       -C-H   stretching 
3. 3159       Aromatic-C-H stretching 
4. 1676       -C=O  stretching 
 
Table 5.4. Functional group assignment of FTIR spectra of CBZ 
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Fig.5.36. FTIR spectra of Kollidon VA64 
Sr. 
No. 
ν (cm)-1 Functional group assignment 
1. 3454 Aromatic -OH stretching. 
2. 2962 Aliphatic -C-H stretching 
3. 1739 -C=O  stretching 
4. 1678 -C=O  stretching 
 
Table 5.5. Functional group assignment of FTIR spectra of Kollidon 
VA64 
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Fig.5.37. FTIR spectra of 5% SD 
Sr. 
No. 
ν (cm)-1 Functional group assignment 
   1. 3460 Aromatic -OH stretching. 
   2. 2963 Aliphatic -C-H stretching 
   3. 1736 Aromatic -C=O stretching 
 
Table 5.6. Functional group assignment of FTIR spectra of 5% SD 
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Fig.5.38. FTIR spectra of 10% SD 
Sr. No. ν (cm)-1 Functional group assignment 
   1. 3462  Aromatic    O-H stretching 
   2. 2962 -CH stretching. 
   3. 1738  C=O stretching 
   4. 1676  Aromatic -C=C stretching. 
 
Table 5.7. Functional group assignment of FTIR spectra of 10% SD 
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Fig.5.39. FTIR spectra of 20% SD 
Sr. 
No. 
ν (cm)-1 Functional group assignment 
   1. 3462  Aromatic   O-H stretching. 
   2. 2960 Aliphatic -C-H stretching 
   3. 1737 C=O stretching 
   4. 1677 Aromatic  C=C stretching 
 
Table 5.8. Functional group assignment of FTIR spectra of 20% SD 
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Fig.5.40. FTIR spectra of 30% SD 
Sr. No. ν (cm)-1 Functional group assignment 
   1. 3464  Aromatic   N-H stretching. 
   2. 2960 Aromatic C-H stretching 
   3. 1736 Aromatic C=O stretching 
   4. 1676 Aromatic  C=C stretching 
 
Table 5.9. Functional group assignment of FTIR spectra of 30% SD 
In the FTIR spectra of 5%, 10%, and 20% SDs, there are no prominent 
peaks of CBZ since it was in less concentration (Fig. 5.35. to Fig. 5.39.). 
While in 30% SD, there is prominent peak of Aromatic C-H str. started 
coming out at 1592 cm-. There is also a sharp peak at 3464 cm-1   in spectra 
of 30% SD (Fig.5.40.) which may be because of intramolecular hydrogen 
bonding of NH2 of CBZ with nitrogen or C=O of acetate or pyrrolidone of 
Kollidon VA64 which indicates formation of solid dispersion (Czernicki and 
Baranska, 2013). 
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5.2.15. Powder X-ray diffraction results 
 
Fig.5.41. X-Ray diffraction patterns of CBZ, Kollidon VA64 and solid 
dispersions (5%, 10%, 20% and 30%) 
The solid state of CBZ and its solid dispersions with Kollidon VA64 were 
studied by PXRD. The powder diffraction patterns of pure CBZ (Fig. 5.41.) 
showed characteristic high intensity diffraction peaks at 2θ values of 15.04̊, 
15.38̊, 15.87̊, 27.38̊, 27.60̊, and 32.10 ̊ which matched with previously 
reported value of CBZ (Krahn and Mielck, 1987; Lowes et al., 1987). The 
powder diffraction patterns of all the SDs did not show peaks corresponding 
to CBZ which indicate the conversion into amorphous form. This clearly 
indicates PXRD results have been able to confirm conversion of crystalline 
Carbamazepine in to amorphous solid dispersions along with Kollidon VA64. 
This analysis also gets supportive results from the indications of amorphous 
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form due to the differences in intensities and Raman shifts (wavenumbers) 
from Raman spectroscopic analysis.  
To summarise, results obtained from preparation and characterization of 
solid dispersions of CBZ - Kollidon VA64 have found to be significant. The 
objective of the work was to get amorphous solid dispersions from crystalline 
active pharmaceutical ingredient along with the polymer. From DSC, XRD 
and Raman spectroscopic analysis, it has been found that amorphous solid 
dispersions have been formulated using hot melt extrusion with advantages   
such as a green and continuous process. Raman spectroscopy have been 
found superior to other analytical techniques in terms of quantification of CBZ 
in solid dispersions by TQ analyst generated correlation coefficient results 
(refer back to calibration curve results Fig. 5.34.). Based on the results 
obtained from these studies, we can conclude that Raman spectroscopy will 
be suitable as a PAT tool for in-line quantification of solid dispersions using 
other polymer combinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
120 
 
 
 
5.3. Preparation and characterisation of solid dispersions of 
Carbamazepine and Soluplus 
5.3.1. DSC results 
DSC analysis of Carbamazepine, Soluplus and Carbamazepine - Soluplus 
physical mixtures was carried out. Physical mixtures were prepared by using 
mortar and pestle in concentrations 5%w/w, 10%w/w, 20%w/w and 30%w/w. 
Thermal profiles were generated in the range of 20˚C - 220˚C using a Q2000 
calorimeter from TA Instruments. Temperature calibration was performed 
using an indium metal standard supplied with the instrument at the 
respective heating rate. Accurately weighed samples (3-5mg) were placed in 
aluminium pans using similar empty pans as a reference. A heating rate of 
10˚C min-1 was employed. Measurements were carried out in an inert 
atmosphere by purging nitrogen gas at the flow rate of 50 mL/min. The 
acquired thermo grams were analysed with TA Instruments Universal 
Analysis 2000 software. 
 
Fig. 5.42. DSC profile of Soluplus 
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The DSC thermogram of Soluplus shows an endothermic event at around 
52˚C and reaching its peak at 75˚C (Fig.5.42.) which indicates transition of 
the polymer from the glassy to the rubbery state (Djuris et al., 2013). 
 
                                                                                                                            
                      a)                                                      b) 
 
                        c)                                                    d) 
Fig.5.43. DSC profiles of physical mixtures of Carbamazepine and 
Soluplus: a) 5%, b) 10%, c) 20% and d) 30% 
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Fig.5.44. DSC profiles of Carbamazepine, Soluplus and physical 
mixtures of Carbamazepine and Soluplus (5%, 10%, 20%, and 30%) 
It has been observed that in the DSC thermograms of Carbamazepine- 
Soluplus physical mixtures (Fig. 5.43., 5.44.), intensity of Carbamazepine 
melting endotherm decreases with the increase in Soluplus concentration. 
More intense melting peak can be seen in the DSC profile of 30 % physical 
mixture than that of other concentrations. These results indicate the 
suitability of Soluplus with Carbamazepine for further studies (hot melt 
extrusion). These results are in resemblance with that of reported in the 
literature (Djuris et al., 2013).  
5.3.2. Rheological analysis 
Rheological study of soluplus has been carried out at four temperatures 
(120°C, 140°C, 160°C and 180°C) to determine its stability. 
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Fig. 5.45.Complex viscosity Vs angular frequency plot for Soluplus at 
120°C, 140°C, 160°C and at 180°C 
 
Fig. 5.46. Storage modulus Vs angular frequency plot for Soluplus  at 
120°C, 140°C, 160°C and at 180°C 
Fig. 5.45. of complex viscosity Vs angular frequency shown good results at 
120°C, 140°C, 160°C and at 180°C while when we plotted graph of storage 
modulus Vs angular frequency, results at 120°C have shown low stability of 
Soluplus which can be seen in Fig.5.46. Based on this we decided to choose 
temperatures above 120°C. 
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5.3.3. Preparation of solid dispersions of CBZ and Soluplus using Hot 
melt extrusion  
To study effect of different polymer with Carbamazepine a new system - 
Carbamazepine and Soluplus was selected. Soluplus being a well extrudable 
polymer with the extrusion temperature range suitable with Carbamazepine 
melting was a good choice for study. 
Solid dispersions of carbamazepine (5H-dibenzo [b, f] azepine-5-
carboxamide) and Soluplus were prepared by a hot melt extrusion process 
using a twin screw extruder at a screw speed of 30rpm and at temperatures 
in the range of 130˚C to 170˚C (T1) and 120˚C to 170˚C with  a feed rate of 
0.180Kg/hr.(Table 5.10.).  
 
 Zone 
T (°C) Die 10 9 8 7 6 5 4 3 2 
T1 170 170 170 150 150 150 140 140 140 130 
T2 170 160 160 160 150 140 120 120 120 120 
 
Table 5.10.Temperature (°C) profiles used during hot melt extrusion 
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                           a) 5% SD                                    b) 10%SD  
 
    
 
                          c)  20%SD                                    d) 30%SD  
 
Fig.5.47. Photographic images of Solid dispersions of CBZ – Soluplus 
 
Photographic images of Solid dispersions of CBZ - Soluplus have been taken 
using digital camera (Sony 16.1 megapixel). As it can be seen from Fig. 5.47. 
a, b, c and d there was yellow coloration as per increase in concentration of 
extrudates was observed in SDs. To find out degradation mechanism based 
on these observations, comparative study of Raman spectra of extrudates 
with that of metabolite of carbamazepine, 5H-Dibenz (b, f) azepine 
(Iminostilbene) was carried out. In-line monitoring of Carbamazepine - 
Soluplus solid dispersion preparation using Raman spectroscopy during hot 
melt extrusion process. 
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Fig.5.48. Raman spectra of CBZ, 5H-Dibenz (b, f) azepine, Soluplus and 
solid dispersions of CBZ-Soluplus (5, 10, 20, 30%) off-line 
 
Fig.5.49.Raman Spectra of 5% CBZ-Soluplus (in-line 120-170°C) 
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Fig.5.50.Raman Spectra of 10% CBZ-Soluplus (in-line 120-170°C) 
 
Fig.5.51.Raman Spectra of 20% CBZ-Soluplus (in-line 120-170°C) 
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Fig.5.52.Raman Spectra of 30% CBZ-Soluplus (in-line 120-170°C) 
In-line Raman spectroscopic analysis of CBZ, 5H-Dibenz (b, f) azepine, 
Soluplus and solid dispersions of CBZ-Soluplus (5, 10, 20, and 30%) has 
been carried out using Inphotonics Raman probe. Spectra were converted 
into Grams format using Grams 9.1 by Thermoscientific. From Fig.5.48. it 
can be seen that in the Raman spectra of solid dispersions there is no 
presence of peaks of 5H-Dibenz (b, f) azepine (Iminostilbene) which is a 
metabolite of carbamazepine. So even though extrudates are showing yellow 
colour, this data indicates absence of any metabolite as well as absence of 
crystallinity of CBZ in the extrudates. During in-line Raman spectroscopic 
analysis, resemblance in peaks of solid dispersions obtained and 5H-Dibenz 
(b, f) azepine (Iminostilbene) was observed (Fig. 5.49. to Fig. 5.52.) From 
these results we can conclude that there might be formation of metabolite of 
CBZ i.e. 5H-Dibenz (b, f) azepine (Iminostilbene) in the temperature profile 
used during hot melt extrusion in the range of 120- 170° C.  
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5.3.4. Raman spectroscopy results 
Off-line Raman spectroscopic analysis 
Off-line Raman analysis of Carbamazepine, Soluplus and Carbamazepine - 
Soluplus SDs was carried out using the Thermo Scientific DXR Smart 
Raman spectrophotometer by placing samples in transparent containers 
using universal platform after calibration and background corrections in the 
range of 200-3500cm- 1. Raman spectra were converted into Grams format 
for interpretation using GRAMS 9.1 spectroscopy software suite, Thermo 
Fisher Scientific Inc. Laser power of 80mW was used with warm up time of 
5min. Two scans of 120s acquisition were collected. These results can be 
seen in Fig. 5.53, to Fig.5.56 .  
 
 
Fig.5.53. Off-line Raman spectra of CBZ – Soluplus SDs (T2 = 120-
170°C) 
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Fig.5.54. Off-line Raman spectra of CBZ – Soluplus SDs (T1 = 130-
170°C) 
 
Fig.5.55. In-line Raman spectra of CBZ – Soluplus SDs (T2 = 120-170°C) 
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Fig. 5.56. In-line Raman spectra of CBZ – Soluplus SDs (T1 = 130-170°C) 
In-line Raman spectroscopic analysis 
In-line Raman spectroscopic analysis of Carbamazepine, Soluplus and solid 
dispersions of Carbamazepine - Soluplus (5, 10, 20, and 30%) has been 
carried out using Inphotonics Raman probe with 80mW laser power and 2 
scans of 60s acquisition. Spectra were converted into Grams format using 
Grams 9.1 by ThermoScientific.   
Prediction of Carbamazepine degradation during hot melt extrusion using in-
line Raman spectroscopic monitoring an application of Process Analytical 
Technology has been carried out. A comparative study of Raman spectra of 
extrudates with that of metabolite of carbamazepine, 5H-Dibenz (b, f) 
azepine (Iminostilbene) was carried out.  
Calibration curve - off-line Raman spectroscopic analysis of CBZ - 
Soluplus SDs 
From the Raman spectra collected off-line using Thermoscientific Raman 
spectrophotometer using ups, a calibration curve has been generated. A 
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partial least square method was used 2 factors was found to give correlation 
coefficient value of 0.7433 for SDs prepared using temperature range of 120-
170°C (T2). This can be seen in Fig.5.57., while SDs prepared in the range 
of 130-170°C (T1) found to show correlation coefficient value of 0.8226 (Fig. 
5.58.). 
 
Fig. 5.57. CBZ - Soluplus SDs off-line Raman calibration curve 120-
170°C 
 
Fig. 5.58. CBZ - Soluplus SDs off-line Raman calibration curve 130-
170°C 
y = 0.8616x 
R² = 0.7433 
-20
0
20
40
60
80
100
0 20 40 60 80 100 120
 M
ea
su
re
d
/c
al
cu
la
te
d
 c
o
n
ce
n
tr
at
io
n
 (
%
) 
 
Actual concentration of CBZ (%) 
 
CBZ-Soluplus SDs off-line Raman calibration curve  
120-170°C 
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CBZ-Soluplus SDs off-line Raman calibration curve 
130-170°C 
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Calibration curve - In - line Raman spectroscopic analysis of CBZ - 
Soluplus SDs 
From the Raman spectra collected using in-line Raman probe by Inphotonics 
during preparation of CBZ - Soluplus SDs using hot melt extrusion, a 
calibration curve has been generated. A partial least square method was 
used with standard normal variate and full spectra were selected for the 
study. Using 2 factors, the calibration curve was found to give correlation 
coefficient value of 0.9704 for SDs prepared using temperature range of 120-
170°. This can be seen in Fig. 5.59. while SDs prepared in the range of 130-
170°C found to show correlation coefficient value of 0.9478 (Fig. 5.60.). 
 
Fig. 5.59. CBZ - Soluplus SDs in-line Raman calibration curve 120-170°C 
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Fig. 5.60. CBZ - Soluplus SDs in-line Raman calibration curve 130-170°C 
Correlation coefficient values obtained from calibration curves of CBZ - 
Soluplus SDs from in-line Raman spectroscopic monitoring have been found 
to be better than those of off-line analysis. These results show that Raman 
spectroscopy is a suitable technique for off-line as well as in-line monitoring 
of CBZ levels in solid dispersions of CBZ - Soluplus. It proves that in-line 
Raman can be used as a PAT tool during hot melt extrusion. 
5.3.5. Hot stage microscopy (HSM) results 
To understand effect of temperature and for the determination of crystalline 
nature of polymorphic forms of Carbamazepine and conversion of its forms 
(form I from heating of form III), hot melt microscopic studied have been 
carried out. Hot stage microscopic analysis of Carbamazepine, Soluplus and 
solid dispersions of carbamazepine and Soluplus obtained by hot melt 
extrusion was carried out. Axiovision software was connected with Link sys 
32 for hot stage. Small amount of samples were placed on open glass slides 
fixed on hot stage with 10 x/0.20 magnifications with bifocal light and heated 
form 30°C to 220°C at 10°C per min. 
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(a)                                                (b) 
         
                          (c)       (d)   
  
Fig.5.61. HSM images of CBZ at a) 165°C b) 179° C c) 190°C and d) 
170°C (cooling) 
Pure carbamazepine form III (p-monoclinic) form started melting (Fig.5.61.a) 
and started converting to form I (triclinic) (Fig.5.61.b). At 190°C melting of 
carbamazepine was observed (Fig.5.61.c). Crystallization on cooling was 
observed. Needle shaped CBZ form I crystals converted from commercial 
CBZ form III can be seen in Fig. 5.61.d. These results are in resemblance 
with those of literature (Djuris et al., 2013).  
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                     (a)                     (b) 
         
                      (c)                                  (d)  
Fig.5.62. HSM images of Soluplus at a) ambient temperature, b) 50°C, c) 
85°C and d) 185°C 
Studying stability of soluplus was of great importance since it was selected to 
be used for preparation of solid dispersion with Carbamazepine. Soluplus 
was heated from 30°C to 220°C at 10°C per min. After 70°C it started 
showing changes and after 185°C it was completely disappeared which 
indicates complete melting. Based on the clear melt it has been concluded 
that there was no sign of degradation of Soluplus up to temperature of 220°C  
 
137 
 
      
                     (a)                 (b)  
     
                      (c)                           (d) 
Fig.5.63. HSM images of 5% SD at a) 126°C, b) 160°C, c) 179°C, d) 190°C 
     
                   (a)         (b) 
     
                    (c)                   (d) 
Fig.5.64. HSM images of 10% SD at a) 126, b) 160, c) 179 and d) 190°C 
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                       (a)                      (b) 
    
                       (c)                   (d) 
Fig.5.65. HSM images of 20% SD at a) 126°, b) 160°C, and c) 179°C d) 
190°C 
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                   (a)                                      (b) 
         
                 (c)                                                         (d) 
Fig.5.66. HSM images of 30% SD at a) 126°C, b) 160°C, c) 179°C, d) 
190°C 
From Fig 5.63. to 5.66. it can be seen that carbamazepine crystals in the 
solid dispersion samples prepared at 120°C-170°C were completely melted 
and got converted into amorphous form which was concluded based on 
absence of any crystals in results. These observations indicate complete 
dissolution of carbamazepine in molten Soluplus. This process might have 
enhanced by hot melt extrusion (shear) in case of SDs prepared by hot melt 
extrusion. After 126°C all solid dispersion samples started to show some 
changes and finally got melted with increase in temperature. Also up to 
170°C - 190°C there was no degradation of carbamazepine was observed. 
Samples were completely got melted at this temperature range. 
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5.4. Preparation and characterization of co-crystals of Ibuprofen and 
Nicotinamide  
Co-crystallization is carried out to obtain crystalline forms of molecules with 
improved quality and is of great importance in pharmaceutical industry in 
order to enhance material properties and in development of overall quality of 
formulations. Use of co-crystals has been reported in literature for stability 
and solubility enhancement, improvement of dissolution rate and 
bioavailability (Dhumal et al., 2010). 
Preparation of co-crystals of Ibuprofen and Nicotinamide has been carried 
out to investigate possible applications of off-line and in-line Raman 
spectroscopy for quantification of co-crystal production during hot melt 
extrusion. The focus of this work was to get solvent free, scalable 
preparation of co-crystals and study of methods for confirmation purity of co-
crystals. 
5.4.1. DSC results 
Thermal profiles of Ibuprofen and Nicotinamide were generated in the range 
of 40 - 170oC using a Q2000 calorimeter from TA Instruments. Accurately 
weighed samples (3-5mg) were placed in aluminium pans using similar 
empty pans as a reference. A heating rate of 10oC min-1 was employed. 
Measurements were carried out in an inert atmosphere by purging nitrogen 
gas at the flow rate of 50 mL/min. The acquired thermo grams were analysed 
with TA Instruments Universal Analysis 2000 software. Meting peak of 
Ibuprofen at 76°C and that of Nicotinamide at 129.5°C can be seen in Fig. 
5.67. and Fig. 5.68. respectively. 
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Fig.5.67. DSC profile of Ibuprofen (m.p. 76°C) 
 
Fig.5.68. DSC profile of Nicotinamide (m.p. 129.5°C) 
5.4.2. Preparation of pure Ibuprofen-Nicotinamide co-crystals by 
Microwave method 
Microwave method has been selected for the preparation of co-crystals of 
Ibuprofen and nicotinamide based on its advantages such as quicker 
method, greener as there is no use of organic solvent as well as user 
friendliness and reproducibility. 
Ibuprofen and Nicotinamide in molar ratio (1:1) were mixed with 82µL of 
distilled water and added in 30 mL capacity glass tube (glass vial type 30). 
Preparation of co-crystals was carried out using Monowave 300 microwave 
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synthesis reactor by Anton Paar. Initially, the temperature chosen was 70°C 
and samples were subjected to microwave irradiation with the holding time of 
1 min and cooled at 40°C. DSC results of co-crystals obtained using these 
parameters did not show pure co-crystal single peak when compared with 
literature (Dhumal et al., 2010). To get pure co-crystals, various batches of 
co-crystals were prepared with different holding times and temperatures 
during microwave preparation as mentioned in the table 5.11. The obtained 
Ibuprofen – Nicotinamide co-crystals were finally analysed and their purity 
was confirmed by DSC. Batch C15 with the holding temperature of 80°C with 
cooling temperature of 40°C was found to produce pure co-crystals which 
was confirmed by DSC. 
Batch name Heating 
temperature 
(°C) 
Holding 
time  
(min) 
 
Cooling 
temperature 
 (°C) 
C1 70 1 40 
C2 70 2 40 
C3 70 3 40 
C4 75 1 40 
C5 75 2 40 
C6 75 3 40 
C7 80 1 40 
C8 80 2 40 
C9 80 3 40 
C10 70 5 40 
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C11 75 5 40 
C12 80 5 40 
C13 70 5 40 
C14 75 5 0 
C15 80 5 40 
A,B,C,D,E 80 5 40 
     
Table 5.11.  Microwave reactor parameters used in the preparation of 
Ibuprofen-Nicotinamide co-crystals. 
5.4.3. DSC results of co-crystals and calibration curve  
Thermal profiles were generated in the range of 40 - 170°C using a Q2000 
calorimeter from TA Instruments. Accurately weighed samples (3-5mg) were 
placed in aluminium pans using similar empty pans as a reference. A heating 
rate of 10°C min-1 was employed. Measurements were carried out in an inert 
atmosphere by purging nitrogen gas at the flow rate of 50 mL/min. The 
acquired thermo grams were analysed with TA Instruments Universal 
Analysis 2000 software. DSC profiles converted into text files and graphs 
were generated in Microsoft excel. 
Melting endotherm of Ibuprofen can be seen at 76°C while melting 
endotherm of Nicotinamide can be seen in the range of 129°C -130°C 
(Fig.5.69., 5.70., 5.71). 
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Fig. 5.69. DSC profiles of Ibuprofen (I), Nicotinamide (N) Ibuprofen- 
Nicotinamide co-crystals (Batches C1-C9)
 
Fig.5.70. DSC profiles of Ibuprofen (I), Nicotinamide (N) Ibuprofen-
Nicotinamide co-crystals (80°C, 5min, 40°C) Batches C10-C15 
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DSC profiles of Batches C1 To C14 were found to show impurity peaks 
below 80°C (Fig.5.69., Fig.5.70.) which disappeared in the DSC profile of 
Batch C15 (Fig 5.70.) at temperature 80°C with holding time of 5min. Based 
on this, settings which produced pure co-crystals (C15) were considered as 
the ideal settings. Using these settings, 5 batches of co-crystals A, B, C, D 
and E were prepared to get reproducibility of results and to get more sample 
for preparation of dilutions of Ibuprofen with co-crystals of Ibuprofen and 
nicotinamide. DSC profiles of batches A, B, C, D and E found to show pure 
co-crystals without any impure peaks (Fig.5.71.). 
 
Fig.5.71. DSC profiles of Ibuprofen (I), Nicotinamide (N) Ibuprofen-
Nicotinamide co-crystals (80°C, 5min, 40°C) Batches A, B, C, D, E 
DSC profiles obtained in Trios format were exported in Microsoft excel for 
generation of calibration curve using enthalpy values. A calibration curve has 
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Ibuprofen-nicotinamide co-crystals with Ibuprofen against measured 
concentration of dilutions co-crystals with Ibuprofen from DSC enthalpy data. 
 
 
Fig.5.72. Calibration curve generated for INA dilutions with ibuprofen 
concentration (actual) Vs Measured concentration (%) from DSC 
enthalpy 
Coefficient of correlation of 0.9641 was obtained from calibration curve (Fig. 
5.72.).  
5.4.4. PXRD results (co - crystals prepared by microwave reactor 
method) 
Crystallinity of co-crystals along with pure ibuprofen and nicotinamide has 
been determined by X-ray powder diffraction using a Bruker D8 
diffractometer (wavelength of X-rays 0.154 nm Cu source, voltage 40 keV, 
and filament emission 40 mA). Samples were scanned in the range of 2 to 
40° (2θ) using a 0.01° step width and a 1s time count. The receiving slit was 
1° and the scatter slit was 0.2°. PXRD patterns of co-crystals (C1), pure 
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ibuprofen and pure nicotinamide have been shown in the Fig. 5.73., 5.74. 
and 5.75. 
 
Fig.5.73. PXRD patterns of co-crystals of Ibuprofen- Nicotinamide, 
Ibuprofen and Nicotinamide 
 
The characteristic peaks of ibuprofen at 6.10 and 12.21 2˚theta and 
characteristic peak of nicotinamide at 14.8 2˚theta are found to be reduced in 
co crystal diffractogram. Diffraction pattern of co-crystals was found to be 
different from that of its coformers ibuprofen and nicotinamide. These 
observations are found to be in resemblance with that of literature (Soares, 
F.L.F., 2013). 
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Fig.5.74. PXRD patterns of Ibuprofen, Nicotinamide and of co-crystals 
of Ibuprofen and Nicotinamide 
In Fig. 5.74., Ibuprofen peak (6.10) was found to be present in some batches 
between C1-C9. After changing microwave synthesis parameters 
(temperature and holding time), Ibuprofen peak (6.10) was found to be 
absent in co-crystals (Batches A, B, C, D, E). 
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Fig.5.75. PXRD patterns of co-crystals of Ibuprofen- Nicotinamide, 
Ibuprofen and Nicotinamide 
In the PXRD patterns of co crystals (Fig.5.75.) Ibuprofen peak (5-6.10) was 
found to be absent which indicates purity of co crystals. 
5.4.5. FTIR results - calibration curve  
FTIR analysis of Ibuprofen-Nicotinamide (IBU - NA) co-crystal dilutions with 
Ibuprofen (10-100%) has been carried out using Nicolet is50 ATR FTIR by 
Thermoscientific. Samples have been analysed at 32 scans with 4cm-1 
resolution. Calibration curves have been generated from FTIR spectra using 
TQ analyst and Microsoft excel. 
Correlation coefficient value of 0.4293 was obtained from the calibration 
curve generated using data obtained from TQ analyst using 2 factors for IBU-
Na co-crystal dilutions with Ibuprofen (Fig. 5.76.) This was carried out for the 
accuracy of the results. 
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Fig.5.76. Calibration curve - IBU-NA co-crystal dilutions with Ibuprofen - 
2 factors 
Correlation coefficient value of 0.8385 was obtained from the calibration 
curve generated using data obtained from TQ analyst using 3 factors for IBU-
NA co-crystal dilutions with Ibuprofen (Fig. 5.77.) This was carried out for the 
accuracy of the results. 
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Fig.5.77. Calibration curve - IBU-NA co-crystal dilutions with Ibuprofen - 
3 factors 
5.4.6. Raman spectroscopy results 
Raman spectroscopic analysis of Ibuprofen, Nicotinamide and IBU-NA 
co-crystals  
Raman spectroscopic analysis of Ibuprofen, Nicotinamide and IBU-NA co-
crystals was carried out using Thermo Scientific DXR Smart Raman 
spectrophotometer with softwares called OMNIC for dispersive Raman and 
TQ Analyst with Laser power of 80mW, aperture slit size of 25µm.  2 scans 
of 60s acquisition were collected. Offline Raman spectroscopic analysis of all 
physical mixtures of Ibuprofen-Nicotinamide co-crystals with Ibuprofen 
(CoC1 to CoC9 - table no. 5.12.) was carried out using Thermoscientic DXR 
smart Raman spectrometer universal platform. 
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Sample 
name 
 
% of  pure 
Ibuprofen 
 
% of co-crystals of 
Ibuprofen and Nicotinamide 
CoC1 10 90 
CoC2 20 80 
CoC3 30 70 
CoC4 40 60 
CoC5 50 50 
CoC6 60 40 
CoC7 70 30 
CoC8 80 20 
CoC9 90 10 
 
Table 5.12. Table showing dilutions of 100% pure co-crystals of 
Ibuprofen-Nicotinamide with Pure Ibuprofen 
Fig. 5.78. shows Raman spectra of Ibuprofen, nicotinamide and co-crystal of 
Ibuprofen - nicotinamide. Characteristic peak of Ibuprofen corresponding to 
C=O can be seen at 739-740cm -1. (Fig.5.79. and 5.80.)  
In Fig.5.81. Raman spectrum of Nicotinamide can be seen with characteristic 
-C-N-H stretching at 1034cm-1 whereas in Fig.5.82. and Fig. 5.83., Raman 
spectrum shows characteristic peak of 100% pure co-crystal at 792cm-1 with 
peak height and peak area respectively. Figures 5.84. to 5.101. Show 
Raman spectra of co-crystal dilutions with Ibuprofen which has been carried 
out to be used for determination of concentration of Ibuprofen by generating 
calibration curve.  
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Fig. 5.78. Raman spectra of Ibuprofen (Blue), Nicotinamide (Purple) and 
co-crystal of Ibuprofen - Nicotinamide (Red) 
 
 
Fig 5.79. Raman spectrum of Ibuprofen showing -C=O, Ar- C-H peak 
area at 739-740cm
-1
 
 
Fig.5.80. Raman spectrum of Ibuprofen showing -C=O, Ar- C-H peak 
height at 738-739cm
-1
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Fig.5.81. Raman spectrum of Nicotinamide showing -C-N- H stretching 
at 1034cm
-1
 
 
Fig.5.82. Raman spectrum showing characteristic peak (peak height) of 
100% pure co-crystal at 792cm
-1
 
 
Fig.5.83. Raman spectrum showing characteristic peak (peak area) of 
100% pure co-crystal at 792cm
-1 
 
5.4.7. Raman spectroscopic analysis of dilutions of Ibuprofen with IBU-
NA co-crystals - peak area and peak height analysis 
The peak height and peak area analysis has been carried out using TQ 
Analyst from DXR Smart Raman spectrophotometer by Thermo Scientific 
from previously collected full Raman spectra (CoC1 to CoC9). 
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      a)          b) 
Fig. 5.84. Raman spectra showing peak height of CoC 1 a) at 740cm-1 
(3.570) and b) at 792cm-1 (72.388) 
 
 
a) 
 
      b) 
Fig. 5.85. Raman spectra showing peak area of CoC 1 peak at  
a)740cm-1 (12.072) and b) 792cm-1 (960.085) 
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a) 
 
           b) 
Fig. 5.86. Raman spectra showing peak height of CoC 2 peak at a) 
740cm-1 (10.787) and b) 792cm-1 (89.692) 
 
a) 
 
              b) 
Fig. 5.87. Raman spectra showing peak area of CoC 2 peak at  
a) 740cm-1 (74.786) and 792cm-1 (904.357) 
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a) 
 
b) 
Fig. 5.88. Raman spectrum showing peak height of CoC 3 peaks at 
 a) 740cm-1 (7.152) and 792cm-1 (27.886) 
 
a) 
                                                        
b) 
Fig.5.89. Raman spectra showing peak area of CoC 3 peak at a) 739cm
-1
 
(205.234) and b) 792cm
-1
(852.881) 
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a) 
 
b) 
Fig.5.90. Raman spectra showing peak height of CoC 4 peak at a) 
740cm
-1
 (34.199) and b) 792cm
-1
(81.499) 
 
a) 
 
b) 
Fig.5.91. Raman spectra showing peak area of CoC 4 peak at a) 739cm
-1
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(181.011) and b) 792cm
-1
(899.333) 
 
a) 
 
b) 
Fig. 5.92. Raman spectra showing peak height of CoC 5 peak at a) 
740cm
-1
(43.194) and b) 792cm
-1
(117.359) 
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(a) 
 
(b) 
Fig.5.93. Raman spectra showing peak area of CoC 5 peak at  
b) 740cm
-1
( 258.881) and b) 792cm
-1
 (Peak area: 985.634) 
 
a) 
 
b) 
Fig.5.94. Raman spectra showing peak height of CoC 6 peak at 
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 a) 740cm
-1
 (47.832) and b) 792cm
-1
(39.954) 
 
a) 
 
b) 
Fig.5.95. Raman spectra showing peak area of CoC 6 peak at 
a) 740cm
-1
(346.333) and b) 792cm
-1
(371.142) 
 
a) 
 
b) 
Fig.5.96. Raman spectra showing peak height of CoC 7 peak at 
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a) 740cm
-1
(58.597) and b) 792cm
-1
(27.912) 
 
a) 
 
b) 
Fig. 5.97. Raman spectra showing peak area of CoC 7 peak at 
a) 740cm-1 (450.829) and b) 792cm
-1 
(209.074) 
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a) 
 
b) 
Fig.5.98. Raman spectra showing peak height of CoC 8 peak at a) 
740cm
-1
 (46.113) and b) 792cm
-1
(6.775) 
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a) 
 
b) 
Fig. 5.99. Raman spectra showing peak area of CoC 8 peak at a) 740cm
-
1
(372.309) and b) 792cm
-1
(8.174) 
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a) 
 
b) 
Fig.5.100. Raman spectra showing peak height of CoC 9 peak at a) 
740cm
-1
(55.679) and b) 792cm
-1
(11.237) 
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a) 
 
b) 
Fig.5.101. Raman spectra showing peak area of CoC 9 peak at  
a) 740cm
-1
 (412.616) and 792cm
-1
(33.239) 
 
Generation of calibration curves has been carried out using peak height and 
peak area values obtained from Raman spectra of dilutions of Ibuprofen with 
IBU-NA co-crystals from this analysis (section 5.4.7.). Characteristic peaks 
corresponding to Ibuprofen (740 cm-1) and pure co-crystal of IBU-NA (792 
cm-1) have been selected while selecting peak height and peak area values 
obtained from Raman spectra of all dilutions. 
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Fig.5.102. Calibration curve showing Ibuprofen and IBU-NA co-crystal 
concentration - peak height at 740cm-1 
 
 
 
Fig. 5.103. Calibration curve showing Ibuprofen and IBU-NA co-crystal 
concentration - peak area at 740cm-1 
Correlation coefficient values were obtained from calibration curves 
generated for Ibuprofen and co-crystal concentration using peak height and 
peak area at 740cm-1 (Fig.5.102. and Fig.5.103) however the correlation 
coefficients determined for the fits are relatively low.  
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Fig.5.104. Calibration curve showing IBU-NA co-crystal concentration - 
peak height at 792cm-1 
 
 
Fig.5.105. Calibration curve showing IBU-NA co-crystal concentration - 
peak area at 792cm-1 
From the calibration curves generated from peak height and peak area 
analysis of IBU-NA co-crystal concentration at 792cm-1 which corresponds to 
pure co-crystal of IBU-NA co-crystal, it was observed that low correlation 
coefficient values were obtained (Fig.104. and Fig.105.). This clearly 
indicates peak height and peak area analysis was not completely useful in 
y = 0.8166x + 12.935 
R² = 0.4255 
0
20
40
60
80
100
120
140
0 10 20 30 40 50 60 70 80 90 100
P
e
ak
 h
e
ig
h
t 
 
Co-crystal concentration in dilution with IBU(%) 
IBU-NA Co-C dilutions
with IBU peak height
at 792cm-1
Linear (IBU-NA Co-C
dilutions with IBU peak
height at 792cm-1)
y = 11.403x + 41.368 
R² = 0.7302 
0
200
400
600
800
1000
1200
0 10 20 30 40 50 60 70 80 90 100
P
e
ak
 a
re
a 
 
Co-crystal concentration in dilution with IBU(%) 
IBU-NA Co-C dilutions
peak area at 792cm-1
Linear (IBU-NA Co-C
dilutions peak area at
792cm-1)
169 
 
predicting co-crystal concentration in dilutions of IBU-NA co-crystal with 
Ibuprofen. Also it shows that this analysis is particularly inaccurate at lower 
concentrations of IBU-NA co-crystal. Hence, it was decided to generate a 
calibration curve using chemometric analysis of the full Raman spectra of 
dilutions of IBU-NA co-crystals with pure Ibuprofen (section 5.48). 
5.4.8. Raman spectroscopy - Calibration curve   
To determine purity of co-crystals of Ibuprofen and Nicotinamide and their 
correlation with pure Ibuprofen concentration calibration curve was 
generated using TQ Analyst using the full Raman spectra. 
All spectra (CoC1 to CoC9) were collected using 80mW laser power, 25µm 
slit at 780nm with estimated spot size of 3.1µm and estimated resolution of 
5.0 to 9.2cm-1. 2 scans of 60s acquisition each were collected. New 
chemometric method was created for preparing calibration curve for 
prediction of concentration of Ibuprofen and co-crystals of Ibuprofen and 
Nicotinamide using TQ analyst 8 by Thermoscientific. Partial least squares 
(PLS) method was selected with standard normal variate and second 
derivative spectra were selected for the study. Spectral data normalization 
was carried out by using mean centering technique.  
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Fig.5.106. Calibration curve: Ibuprofen-Nicotinamide co-crystals + 
Ibuprofen using data exported from TQ Analyst to Microsoft excel from 
Raman spectroscopy results 
Coefficient correlation (r2) of 0.9492 with RMSEC (Root mean square error of 
calibration) value of 7.13 was obtained with 1 factor (Fig.5.106.) indicating a 
much better fit than for the peak area and height calibration curves discussed 
in the previous section. 
 
5.5. Preparation and characterization co-crystals of Carbamazepine and 
Nicotinamide 
5.5.1. DSC results 
DSC analysis of co-crystals of Carbamazepine-Nicotinamide has been 
carried out to study thermal properties of co-crystals. In the DSC profile of 
physical mixture a peak at 127ºC indicates melting of Nicotinamide (Fig. 
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5.107.). Presence of a sharp peak at 161.118 ºC indicates melting of pure 
co-crystal of CBZ-NA (Fig. 5.108). 
 
Fig.5.107. DSC profile of Carbamazepine-Nicotinamide physical mixture 
 
Fig.5.108. DSC profile of Carbamazepine-Nicotinamide co-crystal  
 
5.5.2. Calibration curve generation from DSC results 
DSC profiles obtained in Trios format were exported in Microsoft excel for 
generation of calibration curve using enthalpy values. A calibration curve has 
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been generated by plotting a graph of actual concentration of dilutions co-
crystals with CBZ Vs measured concentration of dilutions co-crystals with 
CBZ from DSC enthalpy data. 
 
Fig.5.109. Calibration curve generated for CNA dilutions with CBZ 
concentration (actual) Vs Measured concentration (%) from DSC 
enthalpy 
Coefficient of correlation of 0.6246 was obtained from calibration curve 
(Fig.5.109.).  
5.5.3. FTIR analysis - calibration curve  
FTIR analysis of Carbamazepine-Nicotinamide (CBZ - NA) co-crystal 
dilutions (10-100%) with Carbamazepine has been carried out using Nicolet 
is50 ATR FTIR by Thermoscientific. Samples have been analysed at 32 
scans with 4cm-1 resolution. Calibration curve has been generated from FTIR 
spectra using TQ analyst and Microsoft excel. 
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Fig.5.110. Calibration curve – CBZ-NA co-crystal dilutions with CBZ 
using Microsoft excel (2 factors) 
Correlation coefficient value of 0.9136 was obtained from the calibration 
curve generated using data obtained from TQ analyst using 2 factors for 
CBZ-NA co-crystal dilutions with Ibuprofen (Fig. 5.110.). This was carried out 
for the accuracy of the results. 
5.5.4. Raman spectroscopy - Calibration curve  
Dilutions of co-crystals of Carbamazepine-Nicotinamide (Table 5.13.) with 
Carbamazepine have been prepared by making physical mixtures using 
mortar and pestle. Off-line Raman spectroscopic analysis of these dilutions 
along with physical mixture of Carbamazepine - Nicotinamide (1:1) and co-
crystals has been carried out using DXR smart Raman spectrophotometer by 
Thermoscientific. 
All spectra were collected using 80mW laser power, 25µm slit at 780nm with 
2 scans of 10s acquisition each. 
New chemometric method was created for generating calibration curve for 
prediction of concentration of Carbamazepine and co-crystals of 
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Carbamazepine and Nicotinamide using TQ analyst 8 by Thermoscientific. 
Partial least squares (PLS) method was selected with standard normal 
variate and second derivative spectra were selected for the study. Spectral 
data normalization was carried out by using mean centering technique.  
 
Sample 
name 
 
% of co-crystals of Carbamazepine -
Nicotinamide 
 
% of  pure 
Carbamazepine 
CNA1 90 10 
CNA2 80 20 
CNA3 70 30 
CNA4 60 40 
CNA5 50 50 
CNA6 40 60 
CNA7 30 70 
CNA8 20 80 
CNA9 10 90 
 
Table 5.13. Dilutions of physical mixtures of co-crystals of 
Carbamazepine and Nicotinamide with Carbamazepine. 
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Fig. 5.111. Calibration curve obtained from Raman spectra of dilutions 
of co-crystals of Carbamazepine-Nicotinamide (0-100%) with 
Carbamazepine 
Using TQ analyst 8, coefficient correlation (r2) of 0.978 with RMSEC (Root 
mean square error of calibration) value of 4.66 was obtained with 2 factors 
(Fig. 5.111). 
The value of coefficient of correlation  obtained from calibration curve using 
DSC enthalpy data generated from CBZ - NA co - crystals was  0.6246  
(Fig.5.109.) whereas the correlation coefficient value obtained from Raman 
spectroscopic result - generated calibration (Fig 5.111.) was 0.978. A good 
correlation value has been obtained using Raman spectroscopy. From this 
we can conclude that Raman spectroscopy is more sensitive than DSC. 
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5.5.5. Comparison of FTIR, DSC and Raman curves for CBZ-NA co-
crystal quantity determination 
Co - crystals of CBZ - NA were analysed by DSC, FTIR and Raman 
spectroscopy. Calibration curves were generated using the data obtained 
from these studies. 
 
 
Fig.5.112. Comparison of FTIR, DSC and Raman calibration curves for 
CBZ-NA co-crystal 
Fig.5.112. shows difference between coefficient of correlation obtained from 
calibration curves obtained using these methods. Coefficient of correlation 
value obtained from Raman spectroscopic studies has been found to be 
higher than the coefficient correlation valued obtained from the DSC and 
FTIR calibration curves. This indicates superiority of Raman spectroscopy 
over DSC and FTIR analysis for co-crystal concentration determination in 
addition to its being able to measure this in-line during the manufacture.  
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Chapter 6 - Conclusions and Further work 
The present work was focused on studying suitability of Raman spectroscopy 
as a PAT technique for monitoring of solid dispersion preparation using hot 
melt extrusion. Raman spectroscopy has been used for studying solid 
dispersions of Carbamazepine - Kollidon VA64, Carbamazepine - Soluplus 
as well as co-crystals of Ibuprofen - Nicotinamide and Carbamazepine - 
Nicotinamide. To conclude, key findings from the present work are listed 
below and further work on these topics has been suggested. 
Conclusions   
Experiment 1  
• Solid dispersions of CBZ - Kollidon VA64 with drug loading up to 30% were 
extrudable during HME while 40% drug loading SDs produced a liquid not 
suitable for extrusion.  
• An increase in the concentration of CBZ decreased the solid dispersion Tg. 
• Decrease in complex viscosity with increasing drug loading indicates the 
platicising effect of the drug upon the formulation. 
• Complex viscosity also decreases with increasing shear rate indicating shear 
thinning of the formulation. 
• In order to extrude the formulations it was still necessary to add Triethyl 
acetate (5%) to gain the desired plasticisation for SD preparation. 
Differences between Raman spectra for physical mixtures and solid 
dispersions show the formation of solid dispersions. 
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• From FTIR and Raman spectroscopy there exists the possibility of 
hydrogen bonding between the NH2 group of CBZ with nitrogen or C=O of 
acetate or pyrrolidone of Kollidon VA64. 
• From PXRD it can be confirmed that solid dispersions were prepared and 
the drug was in the amorphous form. 
Experiment 2 
• From rheological studies, Soluplus was found to be stable (for extrusion) 
above 140°C. 
• During hot stage microscopic studies no sign of degradation of Soluplus 
up to a temperature of 220°C was observed. 
• The correlation coefficient value from the off-line Raman calibration for 
CBZ- Soluplus SDs was found to be reduced when compared to the 
calibration value obtained from in-line Raman calibration. 
• Degradation mechanism of CBZ was studied based on yellow colouration 
of SDs. 
Experiment 3 
• An optimised and reproducible method was developed for the preparation 
of IBU-NA co-crystals using microwave radiation. Variation of 
temperature and holding time confirm the impact of microwave power on 
co-crystal purity as confirmed by DSC, PXRD as well as Raman and 
FTIR spectroscopies. 
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• IBU-NA co-crystals were diluted with further IBU to produce calibration 
samples of known percentage co-crystals. Calibration curves for these 
were produced using DSC as well as Raman and FTIR spectroscopies. 
Experiment 4 
• CBZ-NA co-crystals were prepared using a solvent method and dilutions 
with further CBZ were prepared for the construction of calibration curves 
using Raman and FTIR spectroscopies as well as DSC. 
• A higher correlation coefficient value for the calibration curve produced 
using Raman spectroscopy, compared to those for DSC and FTIR 
calibration curves, indicates the potential for the use of Raman as an 
accurate in-line PAT tool. 
Further work 
 In-line Raman spectroscopic monitoring of solid dispersions of CBZ - 
Kollidon VA64 should be carried out using series collection tool in Omnic 
software. Preliminary work using this technique with CBZ-Soluplus SD 
manufacture has been carried out since thesis submission showing 
promising results. 
 Analysis of co-crystals of IBU-NA prepared using solvent-evaporation 
method needs to be completed (PXRD, DSC, FTIR and Raman 
spectroscopic analysis). These results can then be compared to the 
extrusion-based manufacturing of IBU-NA co-crystals (after preparation) 
as well as to the co-crystals manufactured using microwave radiation. 
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 PXRD analysis of co-crystals of CBZ-NA was not carried out due to the 
working condition of the Bruker diffractometer and this should be 
performed to further prove efficient co-crystal manufacture. 
 Microwave method for the preparation of co-crystals of CBZ-NA can be 
developed through variation in temperature and holding time in the similar 
manner used for the preparation of IBU-NA co-crystals. 
 Preparation of CBZ - NA co-crystals by HME and its in-line monitoring 
using Raman spectroscopy should be performed. As part of this study, in-
line Raman spectroscopic monitoring results should be compared to off-
line Raman spectroscopic analysis carried out on samples collected from 
various zones of extrusion (feeding/mixing/towards die etc.). This would 
allow application of Raman as a PAT tool for co-crystal manufacture as 
well as determining the mechanism of co-crystal formation. 
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Appendices 
Appendix 
A - 1 
Published work at conference 
Presented a poster entitled “Prediction of Carbamazepine metabolite 
formation during hot melt extrusion using Raman spectroscopy - an 
application of Process Analytical Technology” at APS UK Pharm Sci 2014. 
A - 2  
HPLC 
Simultaneous estimation of Carbamazepine and Iminostilbene by HPLC 
and calibration curve generation 
During preparation of solid dispersions of Carbamazepine and Kollidon VA64 
by hot melt extrusion yellow colour have been noticed which gave a reason 
to find out degradation mechanism of Carbamazepine. To understand 
Carbamazepine degradation or formation of its metabolite Iminostilbene, 
simultaneous HPLC of Carbamazepine and Iminostilbene was carried out 
using HPLC.  
HPLC separations were carried out using Waters alliance e2695 HPLC 
system with Empower software. UV absorbance was monitored at 210nm 
and 219nm using Photodiode Array detector. Mobile phase was prepared 
(Table A - 2.1.) and allowed to sonicate for 10 minutes to remove air bubbles 
using Fisher brand sonicator. Table A - 2.2. indicates gradient proportions 
used for HPLC. 
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HPLC parameters: 
 
Column Symmetry C18 100°A 4.6mm×250mm 
1pKg reversed phase by Waters  
Mobile phase A: Distilled water + 0.1% Formic acid 
B: Acetonitrile + 0.1% Formic acid 
Column temperature 27°C 
Sample injection volume 20µL ( 3 injections of each dilution and 
2 injections of stock solutions) 
Needle wash Acetonitrile  
 
Table A - 2.1.  HPLC parameters (Mobile phase) 
Time 
(min) 
Flow A% B% C% D% 
- 1.50 98.0 2.0 0.0 0.0 
6 1.50 2.0 98.0 0.0 0.0 
10 1.50 98.0 2.0 0.0 0.0 
15 1.50 98.0 2.0 0.0 0.0 
 
Table A - 2.1. Gradient proportions used for HPLC 
Mean values of area µV sec were obtained from the values obtained from 3 
injections of each dilutions and 2 injections of stock solutions. A graph of 
area Vs concentration (µg/mL) was plotted. Fig. A - 2.1. shows the calibration 
curve for simultaneous estimation of Carbamazepine and Iminostilbene.  
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Fig. A - 2.1. Calibration curve for simultaneous estimation of 
Carbamazepine and Iminostilbene 
From the calibration curve a straight line equation was obtained. Good 
linearity response was obtained with correlation coefficient of 0.9975 with the 
Carbamazepine. While Iminostilbene trend line has found to show correlation 
coefficient of 0.9988. 
Unfortunately, after producing these preliminary calibration curves, the HPLC 
failed and had to go under service. Hence there was not enough time to fully 
characterize the solid dispersions for degradation during the project.  This 
data will be useful further to detect % degradation content of Carbamazepine 
in solid dispersions. See further work section for more details. 
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